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Foreword
The Second Workshop on Age Adjustment, sponsored by the National Center for Health Statistics, focused on important
policy issues related to this widely used index in health statistics, thereby complementing an earlier workshop that was devoted
to technical issues. I am particularly pleased that the recommendations of the Second Workshop have been translated into a
change in Departmental statistical policy effective with Secretary Shalala’s directive of August 26, 1998. I am using this as an
opportunity to thank the participants of the first and second workshops for their contributions to improving the Federal
Government’s statistical practices in the area of health.
Edward J. Sondik, Ph.D.
Director
National Center for Health Statistics
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This report was prepared in the Division of Vital Statistics. Susan A. Hawk and Kimberley D. Peters of
the Division of Vital Statistics served as facilitators during the workshop. Jennifer Madans provided
helpful comments and suggestions. The Registration Methods staff and the Data Acquisition and
Evaluation Branch of the Division of Vital Statistics provided consultation to State vital statistics offices
regarding collection of the death certificate data on which chapter 3 of this report is based. This report
was edited by Patricia Keaton-Williams and typeset by Jacqueline M. Davis of the Publications Branch,
Division of Data Services.This report contains a summary of
the Second Workshop on Age
Adjustment held at the National Center
for Health Statistics on June 5–6, 1997.
The workshop, which was a follow up to
the First Workshop on Age Adjustment
(1991), was held to consider changing
the standard used for age-adjusting
death rates and to develop an
implementation plan. This report
includes follow up to the
recommendations from the first
workshop.
Participants in the second workshop
included representatives from selected
Federal agencies, State health
departments, nongovernmental
agencies, and academia. The
participants recommended that the
current population standard for
age-adjusting death rates be changed
from the 1940 standard million
population to a standard based on a
projected year 2000 population. On
August 26, 1998, the Secretary, U.S.
Department of Health and Human
Services approved the
recommendations of the second
workshop as departmental policy
effective with the 1999 data year. In
addition, the proposed change has
been widely publicized in presentations
to State vital statistics programs and to
Federal agencies.Chapter 1
Introduction
A ge standardization, often called‘‘age adjustment,’’ has been usebroadly for about 150 years to
eliminate the confounding effects of
differences in age composition. In 1844
F.G.P. Neison presented a paper to the
Statistical Society of London in which
he proposed a method to account for t
differences in age composition of
communities when comparing mortality
(1). Since then experts have met at lea
nine times to discuss age adjustment (
Most recently the National Center for
Health Statistics (NCHS) held two
workshops (1991, 1997) to examine
aspects of age-adjusting death rates.
This report provides a description and
the recommendations of the 1997
workshop. This report also provides a
summary of the results and
recommendations of the 1991 worksho
as well as the follow up to those
recommendations. A record of the first
workshop, which addressed technical
issues, can be found in ‘‘Reconsidering
Age Adjustment Procedures: Workshop
Proceedings (3).’’
The crude death rate is a widely
used measure of mortality. However,
crude death rates are heavily influence
by the age composition of populations.
As such, comparisons of crude ratese
t
).
over time or between groups may be
misleading if the groups differ in age
composition. This is relevant, for
example, in trend comparisons of U.S.
mortality given the aging of the U.S.
population over the past few decades
(4). Age adjustment is one of the key
tools used in mortality statistics to
account for the changing age
distribution of the population, and
thereby to make meaningful
comparisons over time and among
groups in the risk of mortality.
Age adjustment by the direct
method requires a standard age
distribution or ‘‘standard population.’’
The selection of an appropriate standard
population is to some extent an arbitrary
decision, i.e., there is no theoretically
correct standard population. In fact there
are few statistical reasons to guide the
selection of a standard (5–7). The only
guidance given in the statistical
literature is that the standard population
selected should not be considered
abnormal relative to the populations
being studied. That is, it should reflect a
reasonable age distribution (8). Thus,
the choice of a standard has typically
been driven by practical considerations.
Currently, the most commonly used
standard in the United States is based o
the 1940 U.S. population (9). Termed
the ‘‘U.S. standard million population,’’
this standard has been used by NCHS
for age adjustment since 1943. Although

























Page 2 [ Series 4, No. 30reasons to change from the 1940
standard, the question of whether the
public health community would be
better served by a new standard is vali
On March 7, 1991, NCHS convene
the first workshop on age adjustment to
examine technical issues and problems
related to the calculation and
interpretation of age-adjusted death
rates. The first workshop recommended
the continued use of the 1940 standard
by NCHS and encouraged other Feder
and State governmental agencies to us
this standard when publishing official
mortality statistics (10). In addition, the
workshop recommended that NCHS
study issues that might lead to the
introduction of a new or additional
standard by the year 2000.
Recently NCHS and other Federal
agencies have come under renewed
pressure to change standards. The 194
standard is viewed by some as an
anachronistic set of population weights
for two reasons.
+ The 1940 population sounds too old
That is, it gives the impression to
the media and other audiences that
the technical procedures used by th
Federal Government are outdated.
+ The 1940 population has a younger
age distribution than the current
population. Although it is a matter
of judgment as to whether the 1940
population is ‘‘abnormal’’ or
‘‘unnatural’’ relative to the current
population, the negative perceptions
remain.
Further, some agencies have departed
from the 1940 standard in favor of mor
recent standards. At least three differen
standards, based on the 1940, 1970, a
1980 U.S. populations, are used by
Federal agencies (9,11–13). These
multiple standards have led to confusio
among data users and have placed
unnecessary burden on State health
agencies, and have resulted in a renew
emphasis on the need for a single
population standard among
governmental agencies in the publicatio
of mortality statistics.
The Second Workshop on Age
Adjustment was convened by NCHS to
reach agreement on a coordinated




presentation of mortality statistics within
the U.S. Department of Health and
Human Services (DHHS) and among
State health departments. Participants o
the workshop were asked to address
four questions with the goal of
formulating recommendations to the
Secretary, U.S. Department of Health
and Human Services.
+ Should a single standard or multiple
standards be used?
+ Which standard should be used?
+ How often should standards be
updated?
+ How should recommendations of the
workshop be publicized?
Presentations that addressed these
questions were given by representative
from academia, the National Cancer
Institute (NCI), the National Heart,
Lung, and Blood Institute (NHLBI),
NCHS, the National Center for Chronic
Disease Prevention and Health
Promotion, the National Association for
Public Health Statistics and Information
Systems, the National Academy of
Sciences, and the National Committee
on Vital and Health Statistics. See
appendix Ifor the workshop agenda and
appendix IIfor a list of workshop
participants. The presentations were
followed by a facilitated discussion of
the major issues and formulation of
recommendations.
The report proceeds as follows:
Chapter 2 presents the
recommendations, which reflect the
consensus of the workshop participants
Included with each recommendation are
related considerations raised during the
discussion. Chapter 3 contains a
summary of the first workshop and
presents the results of research that
addressed questions raised as a result
the first workshop recommendations.
Chapter 4 provides a summary and
conclusion of the second workshop and
implementation issues. A paper,
‘‘Comments on Age Adjustment,’’ by
Robert Schoen is presented inappendix
III . The purpose of this paper is to
provide background on a proposal that






Nine recommendations resultedfrom the Second Workshop onAge Adjustment. The
recommendations reflect the consensu
of the participants and are listed here
with considerations that were raised
during the development of the
recommendations. In these
recommendations, ‘‘agencies’’ refers to
agencies in DHHS. For comparability
and consistency, it would be
advantageous if the recommendations
were adopted by other Federal agencie
State agencies, and the private sector.
1. The population standard for
age-adjusting death rates should be
changed from the 1940 U.S. standard
million population to the projected
2000 U.S. population to be published
by the Census Bureau in the spring of
1998. A single standard should be used
by all agencies for official presentation
of data. For special analyses,
alternative standards may be used as
appropriate to the research.
Currently, at least three different
standards are used by DHHS agencies
Although most agencies use the 1940
standard, NCI uses a 1970 standard
(11,12), and some centers of the Cente
for Disease Control and Prevention use
a 1980 standard (13). There is a need
for consistency among DHHS agencies
and States when publishing mortality
statistics to minimize confusion and
misunderstanding. Thus, when releasin
official mortality statistics to the public,
age-adjusted death rates should be ba
on a single, uniform standard.
Alternative standards may be used for
special analyses when appropriate. To
avoid confusion researchers should no
their departure from standard practice
when publishing their results.
From a statistical standpoint, when
it is appropriate to standardize, the
choice of population standard matters




































Series 4, No. 30 [ Page 3changing the standard is not a scientific
necessity, there exists a significant
public relations problem related to the
1940 standard. The 1940 population
standard is perceived as outdated and
misrepresenting the current population.
These problems are considered sufficie
reason to discard the 1940 standard an
replace it with a standard that better
reflects the current population.
The projected 2000 population was
chosen as the replacement for the 194
standard. The 2000 standard has the
advantage of being similar in structure
to the current population and will likely
remain so for at least the next 10 years
The 2000 standard has the added appe
of being associated with a millennial
year. Although there is no overriding
statistical reason for choosing the 2000
standard over other age distributions, it
is appropriate to choose a year that is
similar to current reality and with which
data users can be comfortable.
Other standards were considered b
the workshop participants. These
included the life table stationary
population, the projected 2020 U.S.
population, the projected 2050 U.S.
population, and a uniform population
distribution. The life table stationary
population has the advantage of being
hypothetical standard not associated
with a particular year. The concept of a
standard based on a life table’s
stationary population was generally we
received by the workshop participants.
(The rationale for the life table standard
is outlined inappendix III.) However,
the life table standard lacks the
simplicity and intelligibility of the 2000
standard. The projected 2020 and 2050
populations are significantly older than
the current population and could be
viewed in much the same manner as th
1940 population is now viewed. The
uniform population distribution gives
equal weight to each age group.
However, the uniform standard is highly
sensitive to the age categories used. In
addition it is expected that any standar
should reflect a reasonable age
distribution (8).
Implementation of the new 2000
population standard in data year 1999
(see recommendation 2) necessitates t
use of a projected population. Each
spring the U.S. Bureau of the Censust
l
e
releases an updated set of U.S.
population projections. The weights for
the new 2000 standard should be base
on population projections available in
the spring of 1998 from the U.S. Burea
of the Census. Concerns have been
raised regarding the use of a projected
2000 population rather than the actual
2000 Census population. However, the
2000 Census will not be available until
2002 or 2003, which would substantiall
delay implementation. It is very likely
that differences between the actual and
projected populations will be small.
Thus, weights based on the projected
population calculated to five or six
decimal places will be, in all likelihood,
identical to weights based on the actua
Census population. Finally, it is worth
noting that the current 1940 standard is
not based on the enumerated 1940
census population.
2. Agencies should implement the new
population standard by data year 1999
The workshop participants
recommended that official
implementation of the new 2000
standard take place with data year 199
i.e., beginning with publications
reporting 1999 data. NCHS will begin
publishing provisional 1999 data in Jun
1999.
Earlier implementation dates were
considered. However, resource
limitations particularly at the State leve
necessitate a somewhat later
implementation date. Participants from
all agencies were confident that
implementation could become effective
with the data year 1999.
3. Agencies should continue to use and
publish their current standards until
the official implementation data year
(1999) when the new common standar
will be adopted. To avoid confusion,
agencies implementing the new
standard prior to data year 1999 should
simultaneously publish rates adjusted
to both the old and new standards.
Some DHHS agencies indicated a
desire to implement the new standard
before data year 1999. To maintain the
current level of consistency, each agen
will continue to publish age-adjusted
death rates using their current official
standard until data year 1999 when the,
y
new 2000 standard will be used
exclusively for the publication of official
mortality statistics. Rates based on the
new standard may be published before
data year 1999 provided that rates usin
the old standard are also published un
data year 1999.
4. After the implementation date,
agencies should use the new standard
in all press releases and other
communication with the public.
Beginning with data year 1999, all
age-adjusted death rates reported to th
media or to the general public should b
calculated using the new standard. The
statistics will be considered official.
Rates using the old or other standards
may be disseminated for research
purposes as appropriate.
5. NCHS will be responsible for
naming the new standard and will
determine the number of significant
digits.
The new standard will be referred
to as the year 2000 standard populatio
and will be a standard million.
Therefore, weights will be calculated to
six decimal places.
6. Agencies should continue to use the
current 11 age groups (less than 1
year, 1 to 4 years, 5 to 14 years, 15 to
24 years, 25 to 34 years, 35 to 44 yea
45 to 54 years, 55 to 64 years, 65 to 7
years, 75 to 84 years, and 85 years an
older) for calculating age-adjusted
rates using the new standard.
The participants considered two
proposals for expanding the number of
age groups used to calculate age-
adjusted rates. The first was to
disaggregate the 85 years and older
category to 85 to 94 years and 95 year
and older. However, because the
statistical stability of the rates for these
upper age groups was of concern
(especially for small geographical area
the group decided that age-adjusted ra
should continue to be based on the
current standard 10-year age groups.
A second proposal recommended
the use of 5-year age groups in the
calculation of age-adjusted rates. Again
the statistical stability of the rates for
those smaller age groups are a potenti


































Page 4 [ Series 4, No. 30causes of death. It is clear, however, t
in special cases, the standard 10-year
age groups may not be appropriate.
Consequently, population weights will
be made available by 5-year age grou
for special studies.
7. NCHS will convene an
implementation committee that will be
responsible for developing a time table
and strategies for implementation and
for commissioning papers to publicize
the change in standard.
The implementation committee wil
be responsible for addressing the
practical matters related to
implementation of the new
age-adjustment standard. This will
include the development of a time tabl
and strategies for implementation and
the commission of at least two papers—
one technical and one nontechnical—
drawing on publications developed by
NHLBI (14). The committee will also
need to garner support from such offic
and organizations as the Secretary of
DHHS, the DHHS Data Council, all
DHHS agencies, the CDC Excellence
Science Committee, the Committee on
National Statistics of the National
Academy of Science, the National
Cancer Policy Board, the National
Committee on Vital and Health
Statistics, and the Office of Manageme
and Budget.
8. NCHS will publicize the new
standard in NCHS publications, the
Morbidity and Mortality Weekly
Report, Public Health Reports, and
appropriate professional newsletters.
Scholarly papers could also be
published in appropriate professional
and technical journals.
It is important that the new standa
be publicized as widely as possible,
particularly in the public health,
medical, and statistical communities
where age-adjusted death rates are m
used in scientific study and in reports o
health trends. This can be accomplishe
by publications in professional
newsletters and scholarly and technica
journals, particularly those with wide
readership.
In addition to the scientific
community, the public should also be
educated about the new standard int
t
t
particular and age adjustment in gener
e.g., a definition of age-adjusted rates
and an explanation on appropriate usa
This education will take the form of
publications oriented to a nontechnical
audience. NHLBI has taken the lead a
is producing publications designed to
educate the public on age adjustment
(14).
9. NCHS will convene a workgroup to
evaluate the age-adjustment standard
least every 10 years.
It is hoped that the new 2000
standard will be useful for many years.
However, it is probable that another
change will be needed. Therefore, the
workshop participants recommend that
the standard be evaluated at least eve
10 years. A change in the standard
should be made only if differences
between the standard population and t
actual population become problematic.
The results of the second worksho
are nine recommendations to the
Secretary of DHHS. On August 26,
1998, these recommendations were






On March 7, 1991, NCHSconvened the First Workshop oAge Adjustment to examine
technical issues and problems related
the calculation and interpretation of
age-adjusted death rates (3). These
issues arose during the formulation of
the year 2000 health objectives. Amon
the issues examined were historical
perspectives, advantages and
disadvantages of age adjustment, the
effect of the choice of standard on
mortality patterns, and statistical and
nonstatistical considerations in the
selection of standard populations.
Overall the need for age adjustment w
reaffirmed by the workshop participants
A set of four recommendations wa
formulated from the First Workshop on
Age Adjustment (10):,
.
+ NCHS will continue to use the 1940
U.S. population as the basis for
calculating age-adjusted death rate
This population will be converted
into a relative distribution totaling
1,000,000 and will be referred to as
the ‘‘U.S. Standard Million
Population.’’
+ NCHS will study the following
issues that may lead to the
introduction of a new or an
additional standard by the year
2000:
+ The effects on age-adjusted
death rates of using rates for
ages 85–94 years and 95 years
and over, in place of 85 years
and over in their calculation.
+ The feasibility of producing
tables of trends for leading
causes of death from 1960 to th
present for broad age groupings
and the desirability of finer age
adjustment within the broad age
groups.
+ The utility and timeliness of
producing age-adjusted rates
based on the latest decennial
census.
+ NCHS shall develop suitable
technical notes and expository
material concerning the appropriate
use of age adjustment, differences
interpretation from crude and other
rates used in the scientific literature
and clarification of issues expresse
by data users.
+ Other official agencies should use
the standard million population
when publishing age-adjusted
mortality rates. Researchers
examining unique issues might
consider the use of other standard
populations when appropriate and,
minimize confusion, point out this
departure from standard practice.
The first recommendation was that
all should refer to the 1940 population
standard as the ‘‘U.S. Standard Million
Population,’’ which NCHS has done in
its publications since 1991. The third
recommendation was to develop suitab
technical notes and expository materia
concerning age adjustment. NCHS has
also implemented this recommendation
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on age standardization (6). The second
recommendation charged NCHS to
investigate three additional areas:
Expanded age categories—NCHS
examined the effect on age-adjusted
death rates of expanding the number o
age group categories used in the
calculation by disaggregating the 85
years and over group into two
categories—85–94 years and 95 years
Table A compares age-adjusted death
rates for the 15 leading causes of deat
in 1994 using the standard age
categories with rates calculated using
age groups 85–94 and 95 years. The
effect of using the different age groups
is negligible for virtually all of the 15
leading causes of death (seetable 1for
other causes). For example, for heart
disease the age-adjusted rate calculate
using the standard age groups is 140.4
per 100,000 standard population,
compared with 139.7 when calculated
using the 85–94 and 95 and over age
categories. The difference between the
rates is only 0.49 percent. For most of
the 15 leading causes of death, the
difference in rates resulting from these
two procedures is less than 1 percent. A
similar result is obtained when the 1990Table A. Age-adjusted death rates for 15 leading c
expanded 10-year age groups: United States, 199
[Age-adjusted death rates are calculated per 100,000 U.S
15–24, 25–34, 35–44, 45–54, 55–64, 65–74, 75–84, and
expanded to include the age groups 85–94 years and 95
Rank1 Cause
. . . All causes . . . . . . . . . . . . . . . . . . .
1 . . . . . . . Diseases of heart . . . . . . . . . . . . . .
2 . . . . . . . Malignant neoplasms, including neoplas
3 . . . . . . . Cerebrovascular diseases . . . . . . . . .
4 . . . . . . . Chronic obstructive pulmonary diseases
5 . . . . . . . Accidents and adverse effects . . . . . .
. . . Motor vehicle accidents . . . . . . . . .
. . . All other accidents and adverse effect
6 . . . . . . . Pneumonia and influenza . . . . . . . . .
7 . . . . . . . Diabetes mellitus . . . . . . . . . . . . . .
8 . . . . . . . Human immunodeficiency virus infection
9 . . . . . . . Suicide . . . . . . . . . . . . . . . . . . . .
10 . . . . . . . Chronic liver disease and cirrhosis . . .
11 . . . . . . . . Homicide and legal intervention . . . . .
12 . . . . . . . Nephritis, nephrotic syndrome, and neph
13 . . . . . . . Septicemia . . . . . . . . . . . . . . . . . .
14 . . . . . . . Alzheimer’s disease . . . . . . . . . . . . .
15 . . . . . . . Atherosclerosis . . . . . . . . . . . . . . .
0.0 Quantity more than zero but less than 0.05.
*Beginning with data year 1987, the National Center for Health Sta
that these categories are not part of the Ninth Revision, Internation
1Rank based on number of deaths.e
population is used as the standard (see
tables Aand1).
NCHS does not currently produce
death rates for specific age groups olde
than 85 years because of problems in
age reporting and instability in
population estimates at the older ages.
These issues are presently being
examined. As the U.S. population ages
and life expectancy increases, NCHS
will be under pressure to present
mortality statistics in more detail for the
older age groups. In 1994 the life
expectancy of white females at birth
was 79.6 years; at age 65 years, it was
84.1 years (16). When NCHS begins to
routinely show age-specific death rates
separately for the age groups 85–94
years and 95 years, NCHS can
consider expanding the age categories
the standard population to match these
more detailed categories. Because the
effects of expanding the age categories
would be inconsequential, comparabilit
with years before the change will not b
substantially affected.
Age adjusting for broad age
groups—NCHS examined the feasibility
of producing trend tables for leading
causes of death for three broad age
groupings—0–24, 25–64, and 65 yearsauses of death using National Center for Health Sta
4
. standard population. National Center for Health Statistics
85 years and over. Expanded 10-year age groups are the N
years and over]
of death (ICD–9 category)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . .(390–398,402,404–429)
ms of lymphatic and hematopoietic tissues . . . (140–208)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (430–438)
and allied conditions . . . . . . . . . . . . . . . . . (490–496)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . (E800–E949)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . (E810–E825)
s . . . . . . . . . . . . . . . . . . . .(E800–E807,E826–E949)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (480–487)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (250)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . (*042–*044)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . (E950–E959)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (571)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . (E960–E978)
rosis . . . . . . . . . . . . . . . . . . . . . . . . . . . (580–589)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (038)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (331.0)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (440)
tistics introduced categories *042–*044 for classifying and coding Hu
al Classification of Diseases, 1975.r
n
and over—and age adjusting within eac
of the broad groups. These broad age
groups are useful from a programmatic
standpoint and for showing complex
patterns.Table Bshows unadjusted and
age-adjusted death rates from 1979 to
1994 for selected causes of death for
these three broad age groups.Tables 2
and3 show these data for 72 selected
causes of death, Human
immunodeficiency virus infection, and
Alzheimer’s disease.
Age adjusting within the broad age
groups does result in cases of trends th
differ from those based on unadjusted
rates. In the top panel oftable B,
unadjusted and age-adjusted rates are
compared for all causes of death
combined. For all causes at the younge
ages (0–24 years), the trends based on
unadjusted and age-adjusted rates are
virtually the same. In contrast, among
the older age groups, the rate of chang
is substantially different depending on
which type of rate is used. This is
particularly true for the age group 65
years and over where the percent chan
is 0.92 percent for the unadjusted rates
and 9.07 percent for the age-adjusted
rates. The difference in trends reflects
the shifts in the age distribution thattistics 10-year age groups and
10-year age groups are under 1 year, 1–4, 5–14,




























man immunodeficiency virus infection. The asterisks indicate
s
f
Table B. Unadjusted and age-adjusted death rates for selected causes of death for all ages and by three broad age categories:
United States, 1979–94
[Unadjusted rates per 100,000 population in specified group; age-adjusted death rates per 100,000 U.S. standard population]





Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 852.2 875.4 2.72
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 577.1 507.4 –12.07
0–24 years
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121.0 88.1 –27.17
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117.6 85.6 –27.20
25–64 years
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 500.2 398.6 –20.31
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 461.5 403.4 –12.59
65 years and over
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5,060.5 5,014.1 –0.92
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4,317.9 3,926.3 –9.07
Malignant neoplasms, including neoplasms of lymphatic and hematopoietic
tissues (140–208)
All ages
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179.6 205.2 14.25
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130.8 131.5 0.54
0–24 years
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5.1 3.6 –29.77
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5.1 3.7 –27.70
25–64 years
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 142.7 115.6 –19.02
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129.6 117.9 –9.00
65 years and over
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 986.6 1,134.5 14.99
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 932.4 1,036.6 11.18
Diabetes mellitus (205)
All ages
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14.8 21.8 47.30
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9.8 12.9 32.24
0–24 years
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.2 0.2 –33.33
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.2 0.2 –26.09
25–64 years
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8.5 10.4 21.90
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7.7 10.6 37.13
65 years and over
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95.3 128.5 34.82
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84.8 110.3 30.08
Diseases of heart (390–398,402,404–429)
All ages
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 326.5 281.3 –13.84
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 199.6 140.4 –29.66
0–24 years
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.5 2.5 –2.78
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2.5 2.4 –2.44
25–64 years
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155.2 89.4 –42.39
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139.2 91.2 –34.45
65 years and over
Unadjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2,256.1 1,840.7 –18.41
Age-adjusted . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,883.2 1,369.2 –27.29
Page 6 [ Series 4, No. 30have occurred within the age group 65
years and over. Consequently, trend
analysis for the three broad age group
benefits greatly by age adjusting within
the groups.Age adjusting within three broad
age groups also has some advantage
over a single age-adjusted rate for all
age groups combined. For some causes
of death, a single summary measure
cannot adequately describe the mortalityexperience of the population over time.
Cancer (malignant neoplasms) is a
notable example. Intable Bage-adjusted
rates for all ages combined for cancer
from 1979 to 1994 show that the risk o




































Series 4, No. 30 [ Page 7very slightly (0.54 percent) over this
period. However, age-adjusted rates f
the three broad age groupings show a
much more complex pattern. For thos
aged 0–24 years, cancer death rates
showed a consistent decline of nearly
30 percent. Age-adjusted rates for tho
aged 25–64 years also declined by
9 percent from 1979 to 1994. In
contrast, age-adjusted cancer death r
for the age 65 and over population
increasedby 11 percent from 1979 to
1994.
Trends in age-adjusted death rate
for diabetes show similar limitations o
the single summary measure.
Age-adjusted death rates for diabetes
show a 32-percent increase in risk fro
1979 to 1994 for all age groups
combined. However, this increase is
only evident in the 25–64- and 65-yea
and over age groups. In the 0–24-yea
age group, age-adjusted diabetes
mortality declined by 26 percent over
the same period.
For heart disease from 1979 to
1994, the age-adjusted death rate
declined by nearly 30 percent for all
ages. Although declines are evident in
each of the three age groups, the
distribution of decline is not uniform.
For those aged 65 years and over, th
decline is 27 percent; for those aged
25–64 years, 35 percent, but only
2 percent for those under 25 years of
age.
In terms of quality of data for
cancer and diabetes, there is a clear
advantage to using three age groups
compared with the single summary
measure for presenting trends in
mortality. However, for most other
causes of death, the single value
summary measure works well in
showing trends in ‘‘average’’ risk.
There are some advantages to
presenting age-adjusted death rates f
three broad age groups compared wit
the age-specific death rates for 5- or
10-year age groups routinely produce
by NCHS. Although some information
is lost in collapsing detailed age group
overall trends in mortality can be mor
easily perceived by examining trends
three age categories rather than 11 a
categories in the case of 10-year age
groups or 19 age categories in the ca
of 5-year age groups.s
If NCHS were asked to consider
replacing the current age-adjusted de
rates for all ages with age-adjusted ra
for the three broad age groups, its
response might be as follows:
+ It would be difficult and probably
unwise to discontinue what has
become the most relied upon
summary measure of mortality in
the field of public health. The sing
age-adjusted death rate is highly
useful and only in some cases do
it obscure the complexity of
divergent age-specific trends. A
more thorough analysis requires
age-specific comparisons. If very
broad age groups are used, age
adjustment of these groups is
justified.
+ If NCHS were asked if the
advantages of presenting
age-adjusted death rates for three
broad age groups warrant their
inclusion in public health reports a
a standard fixture along with
age-adjusted rates and age-specifi
rates for 5- or 10-year age groups
the response would be ‘‘probably
not.’’ The potential advantages of
presenting death rates for three
broad age groups over the
presentation of age-adjusted rates
and rates by 5- and 10-year age
groups are probably not substanti
enough to warrant their addition.
Nevertheless, this approach may
useful on a limited basis for speci
types of reports.
Using the most recent decennial
census—NCHS was asked to consider
the utility and timeliness of producing
age-adjusted death rates based on a
population standard derived from the
latest decennial census. NCHS has u
the 1940 standard for over 50 years.
the past staying with one standard
proved to be prudent and efficient,
mainly because of the level of effort
required to recalculate trend tables, e
when much of the data was not
computerized. However, using curren
technology, historic rates can be
recalculated with far less effort. In
addition, while NCHS consistently
adhered to the 1940 standard, other
Federal agencies have discarded it in
favor of more contemporary populatios
d
,
standards. Therefore, it would be useful
to review the population standard every




Two workshops were convened byNCHS to reexamine technical andpolicy issues related to the age
adjustment of mortality statistics. The
first workshop examined technical issues
and problems related to the calculation
and interpretation of age-adjusted death
rates. The results of the second
workshop, the focus of this report, are a
set of recommendations to the Secretary
of DHHS.
Participants of the second workshop
recommended adopting a new standard
based on the 2000 U.S. population to
replace the old standard based on the
1940 U.S. population. Implementing this
recommendation would effect the
following:
+ Bring departmental coherence to the
age-adjustment issue
+ Facilitate public understanding
+ Address technical concerns
In addition, participants recommended
that a periodic review process be
instituted to ensure the continuing
appropriateness of the standard.
Implementation of the year 2000
standard has implications for the
presentation and interpretation of
mortality patterns based on age-adjusted
death rates. Important issues include:
+ Time series showing trends of
age-adjusted death rates must be
recalculated retrospectively as far
back as possible. Age-adjusted death
rates calculated using the 1940
standard will not be comparable to
those calculated using the year 2000
standard.
+ The Healthy People 2010 goals
based on age-adjusted death rates
must be recalibrated to reflect the
change in population standard.
+ The change in standard population is
likely to affect some group
e
t
Page 8 [ Series 4, No. 30comparisons and trends, particularly
for race and ethnic groups and for
selected causes of death. These
effects will be explained.
These and other issues related to
age adjustment will be addressed in a
series of publications and presentations
oriented to the scientific community and
to the public.
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Table 1. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease using
National Center for Health Statistics’ 10-year age groups and expanded 10-year age groups: United States, 1994
[Age-adjusted death rates are calculated per 100,000 using 1940 and 1990 U.S. standard populations. National Center for Health Statistics 10-year age groups are less
than 1 year, 1–4, 5–14, 15–24, 25–34, 35–44, 45–54, 55–64, 65–74, 75–84 years, and 85 years and over. Expanded 10-year age groups are the National Center for
Health Statistics age groups expanded to include the age groups 85–94 years and 95 years and over]
Cause of death (ICD–9 category)
Age-adjusted rates













All causes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 507.4 506.1 849.2 838.0
Shigellosis and amebiasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (004,006) 0.0 0.0 0.0 0.0
Certain other intestinal infections . . . . . . . . . . . . . . . . . . . . . . . . . .(007–009) 0.2 0.2 0.3 0.2
Tuberculosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .(010–018) 0.4 0.4 0.6 0.6
Tuberculosis of respiratory system . . . . . . . . . . . . . . . . . . . . . . .(010–012) 0.3 0.3 0.4 0.4
Other tuberculosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .(013–018) 0.1 0.1 0.1 0.1
Whooping cough . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (033) 0.0 0.0 0.0 0.0
Streptococcal sore throat, scarlatina, and erysipelas . . . . . . . . . . . . . (034–035) 0.0 0.0 0.0 0.0
Meningococcal infection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (036) 0.1 0.1 0.1 0.1
Septicemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (038) 4.0 4.0 7.5 7.5
Acute poliomyelitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (045) – – – –
Measles . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (055) – – – –
Viral hepatitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (070) 0.9 0.9 1.2 1.1
Syphilis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (090–097) 0.0 0.0 0.0 0.0
All other infectious and parasitic diseases . . . . . . . . . . . . . . . . (001–003,005,
020–032,037,039–041,*042–*044,046–054,056–066, 071–088,098–139) 17.5 17.5 18.6 18.5
Malignant neoplasms, including neoplasms of lymphatic and hematopoietic
tissues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (140–208) 131.5 131.5 201.6 201.6
Malignant neoplasms of lip, oral cavity, and pharynx . . . . . . . . . . . (140–149) 2.1 2.1 3.0 3.0
Malignant neoplasms of digestive organs and peritoneum . . . . . . . . (150–159) 29.3 29.3 47.2 47.2
Malignant neoplasms of respiratory and intrathoracic organs . . . . . . (160–165) 40.1 40.1 58.9 58.9
Malignant neoplasm of breast . . . . . . . . . . . . . . . . . . . . . . . . . (174–175) 11.6 11.6 16.5 16.5
Malignant neoplasms of genital organs . . . . . . . . . . . . . . . . . . . (179–187) 13.2 13.2 22.9 22.9
Malignant neoplasms of urinary organs . . . . . . . . . . . . . . . . . . . (188–189) 5.1 5.1 8.4 8.4
Malignant neoplasms of all other and unspecified sites . . . . (170–173,190–199) 17.0 17.0 24.8 24.8
Leukemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (204–208) 4.9 4.9 7.4 7.4
Other malignant neoplasms of lymphatic and hematopoietic tissues . . (200–203) 8.2 8.2 12.6 12.6
Benign neoplasms, carcinoma in situ, and neoplasms of uncertain behavior
and of unspecified nature . . . . . . . . . . . . . . . . . . . . . . . . . . . . (210–239) 1.7 1.7 2.8 2.8
Diabetes mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (250) 12.9 12.9 21.3 21.3
Nutritional deficiencies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (260–269) 0.5 0.5 1.3 1.2
Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (280–285) 0.9 0.9 1.6 1.6
Meningitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (320–322) 0.2 0.2 0.3 0.3
Major cardiovascular diseases . . . . . . . . . . . . . . . . . . . . . . . . . . (390–448) 176.8 175.9 347.9 347.2
Diseases of heart . . . . . . . . . . . . . . . . . . . . . . . . . (390–398,402,404–429) 140.4 139.7 271.2 270.6
Rheumatic fever and rheumatic heart disease . . . . . . . . . . . . . . . (390–398) 1.2 1.2 2.0 2.0
Hypertensive heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (402) 5.0 5.0 8.9 8.9
Hypertensive heart and renal disease . . . . . . . . . . . . . . . . . . . . . . . (404) 0.5 0.5 0.9 0.9
Ischemic heart disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (410–414) 91.5 91.0 178.4 178.2
Acute myocardial infarction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (410) 45.7 45.6 82.8 82.8
Other acute and subacute forms of ischemic heart disease . . . . . . . . . . (411) 0.6 0.6 1.1 1.1
Angina pectoris . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (413) 0.2 0.2 0.3 0.3
Old myocardial infarction and other forms of chronic ischemic heart
disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (412,414) 45.0 44.7 94.1 94.0
Other diseases of endocardium . . . . . . . . . . . . . . . . . . . . . . . . . . . (424) 2.6 2.6 5.7 5.7
All other forms of heart disease . . . . . . . . . . . . . . . . . . (415–423,425–429) 39.7 39.4 75.3 75.0
Hypertension with or without renal disease . . . . . . . . . . . . . . . . . (401,403) 2.2 2.2 4.4 4.3
Cerebrovascular diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . (430–438) 26.5 26.4 56.4 56.2
Intracerebral and other intracranial hemorrhage . . . . . . . . . . . . . . (431–432) 5.0 5.0 8.1 8.1
Cerebral thrombosis and unspecified occlusion of cerebral arteries (434.0,434.9) 2.4 2.4 5.4 5.4
Cerebral embolism . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (434.1) 0.1 0.1 0.3 0.3
All other and late effects of cerebrovascular diseases . . . . . (430,433,435–438) 19.0 18.9 42.6 42.5
Atherosclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (440) 2.3 2.3 6.2 6.2
Other diseases of arteries, arterioles, and capillaries . . . . . . . . . . . (441–448) 5.3 5.3 9.8 9.7
Acute bronchitis and bronchiolitis . . . . . . . . . . . . . . . . . . . . . . . . . . . (466) 0.1 0.1 0.2 0.2
See footnotes at end of table.
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Table 1. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease using
National Center for Health Statistics’ 10-year age groups and expanded 10-year age groups: United States, 1994—Con.
[Age-adjusted death rates are calculated per 100,000 using 1940 and 1990 U.S. standard populations. National Center for Health Statistics 10-year age groups are less
than 1 year, 1–4, 5–14, 15–24, 25–34, 35–44, 45–54, 55–64, 65–74, 75–84 years, and 85 years and over. Expanded 10-year age groups are the National Center for
Health Statistics age groups expanded to include the age groups 85–94 years and 95 years and over]
Cause of death (ICD–9 category)
Age-adjusted rates













Pneumonia and influenza . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (480–487) 13.0 12.9 29.8 29.5
Pneumonia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (480–486) 12.8 12.7 29.3 29.1
Influenza . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (487) 0.2 0.2 0.4 0.4
Chronic obstructive pulmonary diseases and allied conditions . . . . . . . (490–496) 21.0 21.0 38.2 38.1
Bronchitis, chronic and unspecified . . . . . . . . . . . . . . . . . . . . . . (490–491) 0.7 0.7 1.3 1.3
Emphysema . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (492) 3.7 3.7 6.5 6.5
Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (493) 1.5 1.5 2.1 2.1
Other chronic obstructive pulmonary diseases and allied conditions . . (494–496) 15.1 15.1 28.2 28.2
Ulcer of stomach and duodenum . . . . . . . . . . . . . . . . . . . . . . . . . (531–533) 1.2 1.2 2.3 2.2
Appendicitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (540–543) 0.1 0.1 0.1 0.1
Hernia of abdominal cavity and intestinal obstruction without mention
of hernia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (550–553,560) 1.0 1.0 2.3 2.2
Chronic liver disease and cirrhosis . . . . . . . . . . . . . . . . . . . . . . . . . . (571) 7.8 7.8 9.5 9.5
Cholelithiasis and other disorders of gallbladder . . . . . . . . . . . . . . . (574–575) 0.5 0.5 1.1 1.0
Nephritis, nephrotic syndrome, and nephrosis . . . . . . . . . . . . . . . . . (580–589) 4.3 4.3 8.5 8.4
Acute glomerulonephritis and nephrotic syndrome . . . . . . . . . . . . . (580–581) 0.1 0.1 0.1 0.1
Chronic glomerulonephritis, nephritis and nephropathy, not specified
as acute or chronic, and renal sclerosis, unspecified . . . . . . . (582–583,587) 0.3 0.3 0.6 0.6
Renal failure, disorders resulting from impaired renal function,
and small kidney of unknown cause . . . . . . . . . . . . . . (584–586,588–589) 3.9 3.9 7.8 7.7
Infections of kidney . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (590) 0.2 0.2 0.4 0.4
Hyperplasia of prostate . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (600) 0.1 0.1 0.2 0.2
Complications of pregnancy, childbirth, and the puerperium . . . . . . . . (630–676) 0.1 0.1 0.1 0.1
Pregnancy with abortive outcome . . . . . . . . . . . . . . . . . . . . . . . (630–638) 0.0 0.0 0.0 0.0
Other complications of pregnancy, childbirth, and the puerperium . . . (640–676) 0.1 0.1 0.1 0.1
Congenital anomalies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (740–759) 4.4 4.4 4.3 2.0
Certain conditions originating in the perinatal period . . . . . . . . . . . . . (760–779) 5.7 5.7 4.9 0.1
Birth trauma, intrauterine hypoxia, birth asphyxia, and respiratory
distress syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (767–769) 0.9 0.9 0.8 0.0
Other conditions originating in the perinatal period . . . . . . (760–766,770–779) 4.8 4.8 4.1 0.0
Symptoms, signs, and ill-defined conditions . . . . . . . . . . . . . . . . . . (780–799) 6.8 6.7 9.2 7.5
All other diseases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (Residual) 40.2 40.1 75.3 74.8
Accidents and adverse effects . . . . . . . . . . . . . . . . . . . . . . . . (E800–E949) 30.3 30.3 34.9 34.6
Motor vehicle accidents . . . . . . . . . . . . . . . . . . . . . . . . . . . (E810–E825) 16.1 16.1 16.5 16.5
All other accidents and adverse effects . . . . . . . . . . (E800–E807,E826–E949) 14.2 14.2 18.4 18.1
Suicide . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (E950–E959) 11.2 11.2 12.0 12.0
Homicide and legal intervention . . . . . . . . . . . . . . . . . . . . . . . (E960–E978) 10.2 10.2 9.8 9.7
All other external causes . . . . . . . . . . . . . . . . . . . . . . . . . . . (E980–E999) 1.3 1.3 1.3 1.3
Human immunodeficiency virus infection1 . . . . . . . . . . . . . . . . . . (*042–*044) 15.4 15.4 15.9 15.9
Alzheimer’s disease2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . (331.0) 2.5 2.5 6.8 6.8
0.0 Quantity more than zero but less than 0.05.
– Quantity zero.
* Beginning with data year 1987, the National Center for Health Statistics introduced categories *042–*044 for classifying and coding Human immunodeficiency virus infection. The asterisks indicate
that these categories are not part of the Ninth Revision, International Classification of Diseases, 1975.
1Included in All other infectious and parasitic diseases shown above.
2Included in All other diseases (Residual category).
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Table 2. Unadjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age ca tegories: United States,
1979–94
[Rates are per 100,000 population in specified age group]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
All causes
0–24 years . . . . . . . . . . . . . . . . . . 121.02 120.96 114.00 109.61 104.50 103.16 102.96 104.39 102.09 103.12 101.92 99.54 97.14 91.34 91.27 88.14
25–64 years . . . . . . . . . . . . . . . . . 500.21 498.04 481.87 462.65 453.71 445.72 441.41 434.13 426.86 423.20 414.07 406.23 400.72 394.66 400.09 398.64
65 years and over . . . . . . . . . . . . . 5,060.51 5,251.97 5,117.26 5,056.39 5,134.53 5,118.73 5,174.88 5,130.17 5,095.81 5,146.30 5,012.35 4,963.15 4,924.03 4,880.60 5,047.68 5,014.09
Shigellosis and amebiasis (004,006)
0–24 years . . . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.00 0.01 0.00 0.01 0.00 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00
25–64 years . . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
65 years and over . . . . . . . . . . . . . 0.05 0.04 0.04 0.02 0.05 0.04 0.05 0.01 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.02
Certain other intestinal infections
(007–009)
0–24 years . . . . . . . . . . . . . . . . . . 0.14 0.15 0.18 0.18 0.17 0.17 0.13 0.14 0.13 0.11 0.12 0.13 0.16 0.16 0.16 0.25
25–64 years . . . . . . . . . . . . . . . . . 0.04 0.05 0.04 0.04 0.04 0.04 0.03 0.06 0.04 0.03 0.03 0.04 0.04 0.04 0.05 0.06
65 years and over . . . . . . . . . . . . . 0.51 0.65 0.61 0.45 0.58 0.46 0.50 0.50 0.50 0.58 0.60 0.79 0.84 1.00 1.26 1.30
Tuberculosis (010–018)
0–24 years . . . . . . . . . . . . . . . . . . 0.03 0.02 0.03 0.02 0.03 0.04 0.04 0.03 0.04 0.04 0.04 0.04 0.03 0.03 0.02 0.02
25–64 years . . . . . . . . . . . . . . . . . 0.79 0.71 0.72 0.61 0.60 0.61 0.59 0.63 0.59 0.62 0.64 0.61 0.58 0.54 0.49 0.42
65 years and over . . . . . . . . . . . . . 4.57 4.67 4.29 4.12 3.89 3.54 3.58 3.45 3.37 3.69 3.70 3.21 2.95 3.02 2.94 2.69
Tuberculosis of respiratory system
(010–012)
0–24 years . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.01 0.02 0.02 0.01 0.02 0.02 0.01 0.02 0.02 0.02 0.01 0.00 0.01
25–64 years . . . . . . . . . . . . . . . . 0.65 0.58 0.58 0.49 0.47 0.46 0.45 0.47 0.45 0.46 0.47 0.43 0.43 0.39 0.37 0.30
65 years and over . . . . . . . . . . . . 3.82 3.93 3.59 3.43 3.18 2.85 2.90 2.85 2.79 3.00 3.02 2.63 2.32 2.44 2.40 2.18
Other tuberculosis (013–018)
0–24 years . . . . . . . . . . . . . . . . 0.02 0.02 0.02 0.01 0.01 0.02 0.02 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.01
25–64 years . . . . . . . . . . . . . . . . 0.14 0.13 0.14 0.13 0.13 0.15 0.14 0.16 0.14 0.16 0.16 0.18 0.14 0.14 0.12 0.13
65 years and over . . . . . . . . . . . . 0.76 0.73 0.70 0.69 0.72 0.69 0.68 0.60 0.57 0.69 0.67 0.58 0.64 0.58 0.54 0.51
Whooping cough (033)
0–24 years . . . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.00 0.00 0.01 0.01 – 0.01 0.01 0.01
25–64 years . . . . . . . . . . . . . . . . . – – – – – – – – – – – – – – – –
65 years and over . . . . . . . . . . . . . – – – – – – – 0.00 – – – – – – – –
Streptococcal sore throat,
scarlatina, and erysipelas (034–035)
0–24 years . . . . . . . . . . . . . . . . . . 0.01 0.00 0.00 0.00 – – – 0.00 0.00 0.00 0.00 0.00 – – 0.00 0.00
25–64 years . . . . . . . . . . . . . . . . . 0.01 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
65 years and over . . . . . . . . . . . . . 0.04 0.03 0.03 0.03 0.02 0.01 0.02 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.02 0.01
Meningococcal infection (036)
0–24 years . . . . . . . . . . . . . . . . . . 0.28 0.28 0.32 0.26 0.22 0.22 0.19 0.20 0.20 0.20 0.19 0.15 0.15 0.14 0.17 0.19
25–64 years . . . . . . . . . . . . . . . . . 0.09 0.08 0.09 0.07 0.05 0.06 0.04 0.06 0.05 0.05 0.05 0.04 0.03 0.03 0.05 0.05
65 years and over . . . . . . . . . . . . . 0.16 0.17 0.21 0.15 0.14 0.11 0.12 0.11 0.07 0.09 0.13 0.09 0.08 0.09 0.10 0.10
Septicemia (038)
0–24 years . . . . . . . . . . . . . . . . . . 0.48 0.46 0.54 0.49 0.54 0.56 0.57 0.57 0.55 0.53 0.56 0.55 0.52 0.47 0.49 0.47
25–64 years . . . . . . . . . . . . . . . . . 1.78 2.01 2.18 2.22 2.38 2.61 2.76 2.87 2.91 2.88 2.71 2.62 2.58 2.56 2.52 2.60
65 years and over . . . . . . . . . . . . . 22.67 26.78 28.76 31.91 37.17 41.20 47.16 51.09 53.56 56.03 50.29 49.39 50.04 49.21 51.40 49.58
Acute poliomyelitis (045)
0–24 years . . . . . . . . . . . . . . . . . . – – – – – – – – – 0.00 – – – – – –
25–64 years . . . . . . . . . . . . . . . . . 0.00 0.00 – – – – 0.00 – – – – – 0.00 – – –
65 years and over . . . . . . . . . . . . . – 0.01 – – – – 0.01 – – – – – – – – –











Table 2. Unadjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age ca tegories: United States,
1979–94—Con.
[Rates are per 100,000 population in specified age group]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Measles (055)
0–24 years . . . . . . . . . . . . . . . . . . 0.00 0.01 0.00 0.00 0.00 – 0.00 0.00 0.00 0.00 0.03 0.06 0.02 0.00 – –
25–64 years . . . . . . . . . . . . . . . . . 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 – –
65 years and over . . . . . . . . . . . . . – – – – – – – – – – 0.00 – – – – –
Viral hepatitis (070)
0–24 years . . . . . . . . . . . . . . . . . . 0.11 0.12 0.12 0.10 0.12 0.10 0.09 0.08 0.08 0.05 0.08 0.05 0.05 0.04 0.05 0.04
25–64 years . . . . . . . . . . . . . . . . . 0.37 0.37 0.43 0.37 0.38 0.40 0.41 0.42 0.51 0.54 0.60 0.61 0.77 0.82 1.06 1.27
65 years and over . . . . . . . . . . . . . 1.02 1.17 1.06 1.14 1.17 1.11 1.31 1.46 1.66 1.90 2.24 2.43 2.51 2.75 3.19 3.97
Syphilis (090–097)
0–24 years . . . . . . . . . . . . . . . . . . 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.02 0.03 0.03 0.02 0.02 0.01
25–64 years . . . . . . . . . . . . . . . . . 0.04 0.02 0.03 0.03 0.02 0.01 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01
65 years and over . . . . . . . . . . . . . 0.51 0.49 0.37 0.31 0.33 0.29 0.18 0.21 0.19 0.15 0.17 0.15 0.14 0.15 0.12 0.14




0–24 years . . . . . . . . . . . . . . . . . . 0.65 0.62 0.58 0.63 0.61 0.64 0.70 0.78 1.48 1.55 1.71 1.66 1.72 1.67 1.84 1.87
25–64 years . . . . . . . . . . . . . . . . . 1.37 1.42 1.54 1.58 1.88 2.58 3.40 4.61 12.29 14.72 19.00 21.26 24.13 26.84 29.24 32.51
65 years and over . . . . . . . . . . . . . 6.18 7.69 7.72 8.01 8.30 9.03 9.83 10.49 10.91 12.01 12.47 12.03 11.54 11.68 12.24 12.02
Malignant neoplasms, including
neoplasms of lymphatic and
hematopoietic tissues (140–208)
0–24 years . . . . . . . . . . . . . . . . . . 5.14 5.19 4.84 4.98 4.75 4.44 4.35 4.33 4.11 4.00 3.99 3.87 3.85 3.79 3.70 3.61
25–64 years . . . . . . . . . . . . . . . . . 142.71 142.91 139.41 138.35 136.56 136.21 134.64 130.96 128.75 127.02 124.52 123.37 121.30 118.60 117.13 115.56
65 years and over . . . . . . . . . . . . . 986.60 1,011.33 1,008.60 1,023.90 1,033.97 1,045.17 1,051.07 1,062.41 1,067.30 1,076.25 1,095.85 1,111.32 1,117.27 1,121.80 1,133.69 1,134.53
Malignant neoplasms of lip, oral
cavity, and pharynx (140–149)
0–24 years . . . . . . . . . . . . . . . . 0.04 0.03 0.04 0.05 0.04 0.03 0.03 0.04 0.03 0.04 0.04 0.03 0.03 0.03 0.03 0.03
25–64 years . . . . . . . . . . . . . . . . 3.94 3.80 3.62 3.50 3.42 3.35 3.10 3.01 2.83 2.84 2.79 2.71 2.65 2.51 2.55 2.37
65 years and over . . . . . . . . . . . . 17.46 17.41 17.14 17.03 16.59 16.30 16.21 16.02 15.17 15.43 14.88 15.89 15.25 14.87 14.78 14.24
Malignant neoplasms of digestive
organs and peritoneum (150–159)
0–24 years . . . . . . . . . . . . . . . . 0.22 0.26 0.22 0.26 0.22 0.19 0.22 0.18 0.19 0.17 0.18 0.17 0.19 0.19 0.19 0.20
25–64 years . . . . . . . . . . . . . . . . 31.56 30.88 29.98 29.41 28.81 28.74 27.97 26.89 26.40 25.55 24.82 24.70 24.46 24.02 23.91 23.80
65 years and over . . . . . . . . . . . . 300.88 302.48 298.10 296.40 295.36 298.07 293.47 289.76 287.11 284.28 287.91 287.30 283.66 282.87 282.74 281.38
Malignant neoplasms of respiratory and
intrathoracic organs (160–165)
0–24 years . . . . . . . . . . . . . . . . 0.08 0.09 0.08 0.09 0.10 0.10 0.08 0.07 0.06 0.07 0.07 0.07 0.07 0.07 0.06 0.06
25–64 years . . . . . . . . . . . . . . . . 43.42 43.81 43.32 43.48 42.88 42.88 42.54 41.48 41.25 40.77 39.93 39.79 38.36 37.38 36.70 35.45
65 years and over . . . . . . . . . . . . 227.89 240.47 242.72 252.37 259.47 264.90 271.08 277.79 285.67 291.23 300.18 308.51 313.71 317.12 322.18 323.26
Malignant neoplasm of breast
(174–175)
0–24 years . . . . . . . . . . . . . . . . 0.02 0.02 0.02 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.02 0.01
25–64 years . . . . . . . . . . . . . . . . 16.60 16.81 16.33 16.20 15.96 16.08 16.01 15.54 15.32 15.31 14.89 14.75 14.48 13.80 13.52 13.39
65 years and over . . . . . . . . . . . . 67.95 69.88 71.64 72.89 73.20 75.51 75.57 76.24 76.00 78.00 79.65 80.27 79.27 78.44 79.38 78.63











Table 2. Unadjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age ca tegories: United States,
1979–94—Con.
[Rates are per 100,000 population in specified age group]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Malignant neoplasms of genital
organs (179–187)
0–24 years . . . . . . . . . . . . . . . . 0.24 0.25 0.22 0.21 0.24 0.19 0.18 0.16 0.14 0.14 0.14 0.13 0.11 0.12 0.12 0.11
25–64 years . . . . . . . . . . . . . . . . 12.05 11.90 11.53 11.14 10.89 10.56 10.33 10.18 9.71 9.63 9.53 9.60 9.35 9.23 8.88 8.93
65 years and over . . . . . . . . . . . . 129.17 130.87 129.18 130.19 131.85 131.01 131.40 134.02 134.55 137.12 139.69 145.42 147.36 148.36 148.10 147.74
Malignant neoplasms of urinary
organs (188–189)
0–24 years . . . . . . . . . . . . . . . . 0.14 0.12 0.12 0.11 0.13 0.09 0.09 0.10 0.08 0.11 0.09 0.08 0.09 0.08 0.07 0.08
25–64 years . . . . . . . . . . . . . . . . 4.62 4.57 4.43 4.46 4.31 4.20 4.21 4.14 4.09 3.91 4.01 4.00 4.00 3.96 3.89 3.87
65 years and over . . . . . . . . . . . . 49.47 50.17 49.66 49.88 49.41 48.97 48.72 48.42 48.38 48.27 49.29 49.91 50.19 50.80 50.53 51.81
Malignant neoplasms of all other and
unspecified sites (170–173,190–199)
0–24 years . . . . . . . . . . . . . . . . 2.04 2.06 1.97 2.03 1.92 1.85 1.83 1.83 1.76 1.73 1.75 1.72 1.70 1.66 1.70 1.64
25–64 years . . . . . . . . . . . . . . . . 18.62 18.97 18.66 18.61 18.78 18.76 18.99 18.55 18.30 18.09 17.44 16.81 16.95 16.72 16.82 16.64
65 years and over . . . . . . . . . . . . 107.50 111.18 112.01 113.73 115.73 117.52 119.01 122.39 123.51 123.40 122.41 120.13 121.27 122.37 126.61 126.49
Leukemia (204–208)
0–24 years . . . . . . . . . . . . . . . . 1.75 1.72 1.55 1.60 1.48 1.41 1.35 1.36 1.33 1.26 1.24 1.22 1.20 1.21 1.15 1.13
25–64 years . . . . . . . . . . . . . . . . 4.70 4.87 4.57 4.45 4.49 4.53 4.39 4.26 4.13 4.06 4.14 4.09 3.98 4.00 3.97 3.88
65 years and over . . . . . . . . . . . . 37.36 37.99 37.40 38.23 37.78 37.79 38.35 37.96 37.24 37.89 38.86 39.48 40.06 40.05 40.32 40.46
Other malignant neoplasms of lymphatic
and hematopoietic tissues (200–203)
0–24 years . . . . . . . . . . . . . . . . 0.62 0.64 0.64 0.60 0.59 0.55 0.55 0.58 0.49 0.47 0.47 0.43 0.45 0.43 0.38 0.36
25–64 years . . . . . . . . . . . . . . . . 7.19 7.31 6.97 7.11 7.02 7.12 7.11 6.91 6.71 6.86 6.97 6.91 7.07 6.98 6.89 7.24
65 years and over . . . . . . . . . . . . 48.93 50.90 50.74 53.17 54.60 55.10 57.26 59.81 59.68 60.63 62.97 64.42 66.49 66.91 69.05 70.52
Benign neoplasms, carcinoma in situ, and
neoplasms of uncertain behavior and of
unspecified nature (210–239)
0–24 years . . . . . . . . . . . . . . . . . . 0.34 0.36 0.33 0.37 0.34 0.33 0.35 0.39 0.33 0.37 0.32 0.37 0.34 0.35 0.33 0.38
25–64 years . . . . . . . . . . . . . . . . . 1.90 1.92 1.73 1.75 1.63 1.50 1.56 1.52 1.34 1.39 1.33 1.31 1.29 1.31 1.37 1.37
65 years and over . . . . . . . . . . . . . 14.25 14.86 15.33 15.51 15.75 15.74 15.97 15.69 15.63 15.54 15.43 15.28 15.82 15.60 16.25 16.06
Diabetes mellitus (250)
0–24 years . . . . . . . . . . . . . . . . . . 0.24 0.19 0.21 0.21 0.19 0.17 0.18 0.19 0.18 0.18 0.21 0.17 0.18 0.18 0.17 0.16
25–64 years . . . . . . . . . . . . . . . . . 8.54 8.81 8.43 8.18 8.45 7.89 8.06 8.12 8.20 8.61 9.44 9.46 9.51 9.62 10.00 10.41
65 years and over . . . . . . . . . . . . . 95.30 98.69 96.04 94.15 96.61 94.99 96.01 93.96 95.78 98.09 113.42 114.30 115.04 115.66 123.58 128.48
Nutritional deficiencies (260–269)
0–24 years . . . . . . . . . . . . . . . . . . 0.06 0.05 0.05 0.05 0.06 0.03 0.05 0.04 0.05 0.04 0.03 0.03 0.04 0.04 0.04 0.04
25–64 years . . . . . . . . . . . . . . . . . 0.27 0.24 0.22 0.19 0.19 0.17 0.19 0.19 0.16 0.17 0.17 0.17 0.15 0.17 0.16 0.16
65 years and over . . . . . . . . . . . . . 7.41 8.06 7.77 8.09 8.73 8.49 9.15 8.96 8.94 9.06 9.13 8.92 8.70 8.91 9.77 9.65
Anemias (280–285)
0–24 years . . . . . . . . . . . . . . . . . . 0.36 0.32 0.29 0.31 0.33 0.32 0.28 0.28 0.25 0.26 0.27 0.28 0.25 0.33 0.28 0.26
25–64 years . . . . . . . . . . . . . . . . . 0.63 0.63 0.60 0.55 0.60 0.54 0.60 0.54 0.61 0.56 0.63 0.64 0.61 0.62 0.60 0.67
65 years and over . . . . . . . . . . . . . 8.63 8.87 9.03 8.89 9.11 9.35 9.62 9.65 9.57 9.60 9.63 9.74 9.78 9.69 9.93 9.78
Meningitis (320–322)
0–24 years . . . . . . . . . . . . . . . . . . 0.75 0.82 0.72 0.64 0.63 0.57 0.53 0.46 0.45 0.46 0.41 0.38 0.25 0.24 0.22 0.23
25–64 years . . . . . . . . . . . . . . . . . 0.33 0.29 0.35 0.29 0.28 0.27 0.26 0.29 0.31 0.25 0.27 0.27 0.23 0.22 0.21 0.22
65 years and over . . . . . . . . . . . . . 1.34 1.32 1.32 1.34 1.37 1.27 1.45 1.37 1.27 1.43 1.13 1.08 1.14 0.91 0.93 0.80











Table 2. Unadjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age ca tegories: United States,
1979–94—Con.
[Rates are per 100,000 population in specified age group]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Major cardiovascular diseases
(390–448)
0–24 years . . . . . . . . . . . . . . . . . . 3.42 3.83 3.51 3.52 3.74 3.78 3.69 3.72 3.62 3.63 3.20 3.22 3.22 3.11 3.15 3.14
25–64 years . . . . . . . . . . . . . . . . . 184.35 179.95 172.79 164.61 159.99 153.64 148.17 141.29 135.00 129.74 121.44 116.20 112.81 110.47 110.46 108.08
65 years and over . . . . . . . . . . . . . 3,025.74 3,099.23 2,974.10 2,912.38 2,906.01 2,839.49 2,812.87 2,740.06 2,685.52 2,673.81 2,530.61 2,463.60 2,418.25 2,375.11 2,437.96 2,391.45
Diseases of heart
(390–398,402,404–429)
0–24 years . . . . . . . . . . . . . . . . 2.52 2.88 2.68 2.74 2.91 2.98 2.91 3.02 2.93 2.91 2.53 2.53 2.52 2.45 2.42 2.45
25–64 years . . . . . . . . . . . . . . . . 155.21 151.87 146.05 139.62 135.74 130.04 125.57 119.47 113.69 109.00 101.59 96.87 94.02 91.86 91.79 89.41
65 years and over . . . . . . . . . . . . 2,256.05 2,330.41 2,253.52 2,227.21 2,240.05 2,193.26 2,182.08 2,133.93 2,089.34 2,083.18 1,968.60 1,914.03 1,880.98 1,844.51 1,891.03 1,840.67
Rheumatic fever and rheumatic
heart disease (390–398)
0–24 years . . . . . . . . . . . . . . . . 0.11 0.13 0.08 0.10 0.08 0.11 0.10 0.07 0.07 0.08 0.06 0.06 0.04 0.06 0.05 0.07
25–64 years . . . . . . . . . . . . . . . . 2.95 2.82 2.47 2.21 2.16 1.96 1.80 1.65 1.51 1.42 1.29 1.25 1.17 1.10 1.05 0.97
65 years and over . . . . . . . . . . . . 18.23 18.35 17.51 16.75 15.91 16.29 15.44 15.14 15.15 15.22 14.39 14.09 13.89 13.05 13.16 12.20
Hypertensive heart disease (402)
0–24 years . . . . . . . . . . . . . . . . 0.02 0.02 0.02 0.03 0.01 0.02 0.03 0.02 0.02 0.03 0.02 0.02 0.03 0.02 0.02 0.02
25–64 years . . . . . . . . . . . . . . . . 5.40 5.10 5.08 4.76 4.77 4.49 4.47 4.23 4.23 4.11 4.06 3.92 3.91 4.04 4.05 4.27
65 years and over . . . . . . . . . . . . 60.73 61.07 57.95 57.52 56.79 55.51 54.81 53.11 52.32 52.03 51.65 51.75 51.30 51.25 53.88 54.89
Hypertensive heart and renal
disease (404)
0–24 years . . . . . . . . . . . . . . . . 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.01 0.00
25–64 years . . . . . . . . . . . . . . . . 0.44 0.44 0.38 0.32 0.32 0.27 0.32 0.29 0.30 0.28 0.25 0.29 0.27 0.28 0.26 0.27
65 years and over . . . . . . . . . . . . 12.66 12.65 11.16 9.94 9.89 9.10 8.51 7.42 7.26 6.95 6.73 6.43 6.59 6.59 6.43 6.42
Ischemic heart disease (410–414)
0–24 years . . . . . . . . . . . . . . . . 0.20 0.22 0.24 0.25 0.24 0.26 0.20 0.18 0.20 0.20 0.18 0.18 0.19 0.16 0.19 0.17
25–64 years . . . . . . . . . . . . . . . . 115.40 111.52 106.20 101.21 96.00 90.71 86.03 79.65 74.72 69.97 65.98 62.70 60.33 58.06 56.97 55.23
65 years and over . . . . . . . . . . . . 1,708.36 1,745.15 1,671.31 1,639.50 1,618.28 1,563.15 1,530.60 1,464.19 1,420.40 1,403.48 1,352.67 1,317.57 1,283.19 1,251.68 1,264.80 1,228.38
Acute myocardial infarction (410)
0–24 years . . . . . . . . . . . . . . . . 0.13 0.15 0.15 0.16 0.15 0.14 0.13 0.10 0.12 0.11 0.11 0.11 0.10 0.10 0.09 0.10
25–64 years . . . . . . . . . . . . . . . . 79.03 74.22 69.64 65.98 61.60 57.45 53.43 48.30 44.66 40.99 38.94 36.66 34.97 33.38 32.30 31.27
65 years and over . . . . . . . . . . . . 863.11 860.42 823.21 810.07 789.16 761.62 742.55 699.38 671.58 654.30 645.22 619.14 598.55 575.20 563.41 544.12
Other acute and subacute forms of
ischemic heart disease (411)
0–24 years . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.00 0.00 0.00
25–64 years . . . . . . . . . . . . . . . . 1.57 1.52 1.43 1.30 1.18 1.10 1.10 1.03 0.87 0.76 0.76 0.80 0.75 0.69 0.63 0.58
65 years and over . . . . . . . . . . . . 12.30 12.25 11.34 9.93 9.92 9.86 9.35 8.99 8.32 8.14 7.88 7.46 7.31 7.01 6.49 6.25
Angina pectoris (413)
0–24 years . . . . . . . . . . . . . . . . 0.00 – – 0.00 0.00 0.00 0.00 0.00 – – – 0.00 – 0.00 0.00 0.00
25–64 years . . . . . . . . . . . . . . . . 0.10 0.11 0.11 0.12 0.12 0.15 0.13 0.14 0.12 0.11 0.12 0.09 0.09 0.08 0.09 0.09
65 years and over . . . . . . . . . . . . 1.56 1.72 1.72 1.77 2.20 2.41 2.72 2.84 2.98 2.96 3.00 3.07 2.97 2.76 2.63 2.38
Old myocardial infarction and other forms
of chronic ischemic heart disease
(412,414)
0–24 years . . . . . . . . . . . . . . . . 0.06 0.07 0.08 0.08 0.08 0.10 0.07 0.07 0.08 0.07 0.06 0.07 0.08 0.06 0.09 0.07
25–64 years . . . . . . . . . . . . . . . . 34.70 35.66 35.02 33.81 33.10 32.01 31.37 30.19 29.06 28.11 26.17 25.15 24.51 23.89 23.95 23.28
65 years and over . . . . . . . . . . . . 831.39 870.77 835.03 817.74 817.00 789.26 775.98 752.98 737.52 738.08 696.56 687.91 674.36 666.71 692.27 675.63











Table 2. Unadjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age ca tegories: United States,
1979–94—Con.
[Rates are per 100,000 population in specified age group]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Other diseases of endocardium (424)
0–24 years . . . . . . . . . . . . . . . . . 0.09 0.10 0.08 0.09 0.09 0.09 0.10 0.08 0.09 0.07 0.09 0.08 0.09 0.08 0.06 0.07
25–64 years . . . . . . . . . . . . . . . . 1.43 1.49 1.40 1.38 1.31 1.30 1.33 1.30 1.36 1.34 1.31 1.34 1.23 1.24 1.25 1.21
65 years and over . . . . . . . . . . . . . 19.48 21.42 21.83 23.03 24.84 25.59 27.60 29.27 31.11 33.24 34.11 36.15 37.97 39.23 41.15 41.40
All other forms of heart disease
(415–423,425–429)
0–24 years . . . . . . . . . . . . . . . . . 2.09 2.41 2.25 2.28 2.48 2.51 2.48 2.66 2.55 2.52 2.18 2.18 2.17 2.12 2.09 2.11
25–64 years . . . . . . . . . . . . . . . . 29.59 30.49 30.51 29.74 31.19 31.30 31.62 32.34 31.57 31.89 28.70 27.37 27.11 27.14 28.21 27.45
65 years and over . . . . . . . . . . . . . 436.61 471.76 473.75 480.46 514.34 523.62 545.13 564.81 563.11 572.26 509.06 488.04 488.03 482.71 511.62 497.37
Hypertension with or without renal
disease (401,403)
0–24 years . . . . . . . . . . . . . . . . . 0.03 0.03 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.01 0.03 0.02 0.02 0.02 0.02 0.03
25–64 years . . . . . . . . . . . . . . . . 1.39 1.45 1.35 1.24 1.23 1.24 1.21 1.18 1.15 1.21 1.18 1.20 1.20 1.23 1.40 1.34
65 years and over . . . . . . . . . . . . . 22.99 24.43 23.22 23.00 23.07 22.70 22.21 22.59 22.66 23.05 23.64 24.55 25.07 26.77 28.60 29.99
Cerebrovascular diseases (430–438)
0–24 years . . . . . . . . . . . . . . . . . 0.72 0.78 0.68 0.62 0.67 0.65 0.62 0.53 0.55 0.60 0.53 0.55 0.57 0.52 0.59 0.54
25–64 years . . . . . . . . . . . . . . . . 22.64 21.51 20.63 19.15 18.38 17.88 17.02 16.44 16.03 15.53 14.65 14.33 13.82 13.69 13.61 13.78
65 years and over . . . . . . . . . . . . . 576.59 573.07 534.71 506.47 489.72 476.97 465.71 445.94 438.07 434.05 412.84 403.52 394.10 388.51 401.40 405.15
Intracerebral and other intracranial
hemorrhage (431–432)
0–24 years . . . . . . . . . . . . . . . . . 0.32 0.33 0.30 0.28 0.29 0.28 0.25 0.22 0.20 0.21 0.21 0.19 0.19 0.18 0.18 0.16
25–64 years . . . . . . . . . . . . . . . . 6.30 6.03 5.84 5.56 5.24 5.25 5.13 4.96 5.00 4.92 4.72 4.59 4.45 4.47 4.46 4.56
65 years and over . . . . . . . . . . . . . 58.89 54.80 51.45 50.07 48.11 49.66 50.85 49.33 48.58 49.66 47.43 46.92 46.50 46.83 46.92 46.90
Cerebral thrombosis and
unspecified occlusion of cerebral
arteries (434.0,434.9)
0–24 years . . . . . . . . . . . . . . . . . 0.06 0.06 0.05 0.05 0.06 0.06 0.06 0.05 0.06 0.07 0.06 0.06 0.07 0.04 0.06 0.07
25–64 years . . . . . . . . . . . . . . . . 3.06 2.81 2.45 2.22 2.17 2.08 1.89 1.80 1.68 1.53 1.35 1.32 1.18 1.06 1.00 0.95
65 years and over . . . . . . . . . . . . . 129.05 121.25 107.83 96.39 87.36 81.79 78.20 73.27 68.51 64.10 58.82 53.21 47.58 43.87 42.29 40.10
Cerebral embolism (434.1)
0–24 years . . . . . . . . . . . . . . . . . 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00 – 0.01 – 0.00 –
25–64 years . . . . . . . . . . . . . . . . 0.14 0.14 0.13 0.11 0.09 0.10 0.09 0.08 0.09 0.07 0.06 0.06 0.05 0.05 0.06 0.06
65 years and over . . . . . . . . . . . . . 2.77 2.49 2.52 2.38 2.32 2.34 2.39 2.34 2.14 2.15 1.95 1.87 1.76 1.74 1.72 1.90
All other and late effects of
cerebrovascular diseases
(430,433,435–438)
0–24 years . . . . . . . . . . . . . . . . . 0.34 0.38 0.33 0.29 0.32 0.30 0.31 0.25 0.29 0.32 0.26 0.30 0.31 0.30 0.34 0.31
25–64 years . . . . . . . . . . . . . . . . 13.13 12.54 12.21 11.27 10.88 10.44 9.92 9.60 9.26 9.00 8.51 8.37 8.12 8.11 8.10 8.21
65 years and over . . . . . . . . . . . . . 385.88 394.53 372.90 357.63 351.94 343.19 334.27 321.00 318.84 318.14 304.64 301.52 298.26 296.08 310.47 316.26
Atherosclerosis (440)
0–24 years . . . . . . . . . . . . . . . . . 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
25–64 years . . . . . . . . . . . . . . . . 1.21 1.27 1.16 1.13 1.11 0.96 0.96 0.94 0.90 0.83 0.75 0.70 0.66 0.64 0.61 0.58
65 years and over . . . . . . . . . . . . . 109.52 109.91 101.90 95.33 91.70 83.71 80.13 74.31 72.14 69.90 60.02 55.21 52.18 49.56 50.22 49.25
Other diseases of arteries, arterioles,
and capillaries (441–448)
0–24 years . . . . . . . . . . . . . . . . . 0.15 0.14 0.13 0.12 0.14 0.13 0.14 0.15 0.12 0.10 0.11 0.11 0.11 0.12 0.11 0.11
25–64 years . . . . . . . . . . . . . . . . 3.90 3.86 3.61 3.47 3.52 3.53 3.41 3.26 3.23 3.17 3.27 3.11 3.12 3.06 3.05 2.97
65 years and over . . . . . . . . . . . . . 60.58 61.41 60.75 60.37 61.47 62.84 62.75 63.31 63.31 63.64 65.50 66.30 65.92 65.77 66.71 66.38











Table 2. Unadjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age ca tegories: United States,
1979–94—Con.
[Rates are per 100,000 population in specified age group]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Acute bronchitis and bronchiolitis (466)
0–24 years . . . . . . . . . . . . . . . . . . 0.15 0.15 0.13 0.12 0.12 0.10 0.10 0.09 0.11 0.11 0.11 0.11 0.10 0.13 0.11 0.12
25–64 years . . . . . . . . . . . . . . . . . 0.09 0.10 0.08 0.08 0.08 0.07 0.07 0.05 0.06 0.07 0.06 0.06 0.06 0.06 0.07 0.05
65 years and over . . . . . . . . . . . . . 1.24 1.55 1.37 1.13 1.27 1.33 1.51 1.51 1.26 1.47 1.49 1.44 1.44 1.17 1.43 1.21
Pneumonia and influenza (480–487)
0–24 years . . . . . . . . . . . . . . . . . . 2.07 1.94 1.64 1.55 1.51 1.43 1.43 1.41 1.36 1.35 1.39 1.29 1.32 1.22 1.18 1.14
25–64 years . . . . . . . . . . . . . . . . . 6.14 6.78 6.51 5.72 5.82 5.87 6.30 6.40 6.10 6.53 6.28 6.19 5.96 5.43 5.94 5.71
65 years and over . . . . . . . . . . . . . 145.64 178.13 171.75 153.16 174.70 182.05 207.02 209.60 204.35 226.89 219.67 226.79 217.18 209.11 225.34 219.44
Pneumonia (480–486)
0–24 years . . . . . . . . . . . . . . . . 2.03 1.89 1.59 1.52 1.49 1.40 1.40 1.37 1.34 1.32 1.33 1.25 1.26 1.19 1.14 1.11
25–64 years . . . . . . . . . . . . . . . . 6.09 6.61 6.28 5.65 5.73 5.79 6.18 6.29 6.04 6.44 6.16 6.08 5.87 5.37 5.87 5.62
65 years and over . . . . . . . . . . . . 143.58 168.47 161.42 150.81 169.96 178.56 200.40 203.84 202.56 220.92 215.13 220.64 214.13 206.35 222.59 216.16
Influenza (487)
0–24 years . . . . . . . . . . . . . . . . 0.04 0.05 0.05 0.02 0.03 0.03 0.03 0.04 0.02 0.03 0.06 0.04 0.06 0.03 0.05 0.02
25–64 years . . . . . . . . . . . . . . . . 0.05 0.17 0.22 0.07 0.10 0.08 0.12 0.11 0.06 0.10 0.12 0.12 0.09 0.07 0.07 0.09
65 years and over . . . . . . . . . . . . 2.06 9.67 10.34 2.36 4.74 3.49 6.62 5.76 1.80 5.97 4.54 6.16 3.05 2.76 2.76 3.28
Chronic obstructive pulmonary
diseases and allied conditions
(490–496)
0–24 years . . . . . . . . . . . . . . . . . . 0.34 0.35 0.37 0.44 0.42 0.39 0.42 0.43 0.47 0.42 0.43 0.44 0.48 0.43 0.48 0.49
25–64 years . . . . . . . . . . . . . . . . . 10.77 11.31 11.29 10.74 11.35 11.31 11.55 11.25 11.07 11.19 11.14 10.66 10.70 10.22 10.73 10.54
65 years and over . . . . . . . . . . . . . 152.21 170.60 175.76 177.04 193.36 199.52 213.37 215.97 217.55 227.79 228.05 234.10 240.64 242.24 263.71 262.52
Bronchitis, chronic and unspecified
(490–491)
0–24 years . . . . . . . . . . . . . . . . 0.13 0.09 0.10 0.09 0.08 0.08 0.08 0.07 0.10 0.08 0.08 0.08 0.10 0.08 0.08 0.07
25–64 years . . . . . . . . . . . . . . . . 0.74 0.69 0.65 0.58 0.55 0.52 0.48 0.47 0.43 0.46 0.43 0.42 0.44 0.41 0.40 0.37
65 years and over . . . . . . . . . . . . 10.94 11.35 10.97 10.31 10.51 10.28 10.46 10.75 10.00 10.22 10.24 9.61 9.67 9.48 9.68 9.10
Emphysema (492)
0–24 years . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.01 0.01 0.01
25–64 years . . . . . . . . . . . . . . . . 3.03 2.91 2.69 2.45 2.44 2.32 2.37 2.36 2.28 2.25 2.22 2.14 2.08 1.95 2.10 1.96
65 years and over . . . . . . . . . . . . 41.25 42.08 39.67 37.46 38.36 37.87 39.92 40.09 39.47 42.23 41.28 41.80 43.30 42.78 45.15 43.99
Asthma (493)
0–24 years . . . . . . . . . . . . . . . . 0.17 0.21 0.21 0.29 0.28 0.26 0.31 0.32 0.34 0.31 0.30 0.33 0.35 0.33 0.37 0.39
25–64 years . . . . . . . . . . . . . . . . 1.00 1.04 1.14 1.13 1.31 1.22 1.31 1.24 1.39 1.45 1.45 1.43 1.48 1.37 1.43 1.57
65 years and over . . . . . . . . . . . . 5.51 6.20 6.13 6.05 6.65 6.85 7.22 7.50 7.97 8.36 9.04 8.72 9.04 8.89 8.95 9.11
Other chronic obstructive
pulmonary diseases and allied
conditions (494–496)
0–24 years . . . . . . . . . . . . . . . . 0.02 0.04 0.05 0.05 0.05 0.04 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02
25–64 years . . . . . . . . . . . . . . . . 6.01 6.68 6.81 6.58 7.06 7.24 7.39 7.18 6.97 7.02 7.04 6.67 6.69 6.48 6.80 6.64
65 years and over . . . . . . . . . . . . 94.51 110.97 118.99 123.22 137.85 144.51 155.77 157.64 160.10 166.98 167.48 173.97 178.64 181.09 199.92 200.32
Ulcer of stomach and duodenum
(531–533)
0–24 years . . . . . . . . . . . . . . . . . . 0.05 0.06 0.05 0.04 0.03 0.03 0.03 0.03 0.03 0.05 0.03 0.03 0.02 0.02 0.03 0.03
25–64 years . . . . . . . . . . . . . . . . . 1.39 1.35 1.32 1.23 1.09 1.10 1.04 0.99 0.90 0.89 0.85 0.80 0.81 0.74 0.76 0.76
65 years and over . . . . . . . . . . . . . 17.44 18.05 19.05 19.87 18.62 18.87 18.95 18.14 17.65 17.55 17.47 16.56 15.91 15.92 14.99 15.21











Table 2. Unadjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age ca tegories: United States,
1979–94—Con.
[Rates are per 100,000 population in specified age group]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Appendicitis (540–543)
0–24 years . . . . . . . . . . . . . . . . . . 0.07 0.08 0.05 0.06 0.05 0.04 0.04 0.05 0.03 0.04 0.04 0.04 0.03 0.03 0.04 0.03
25–64 years . . . . . . . . . . . . . . . . . 0.19 0.21 0.15 0.13 0.12 0.11 0.11 0.12 0.10 0.10 0.09 0.10 0.09 0.08 0.09 0.08
65 years and over . . . . . . . . . . . . . 1.66 1.59 1.42 1.20 1.28 1.18 1.19 1.12 1.12 1.02 0.97 0.88 0.75 0.85 0.67 0.71
Hernia of abdominal cavity and
intestinal obstruction without mention
of hernia (550–553,560)
0–24 years . . . . . . . . . . . . . . . . . . 0.28 0.25 0.23 0.23 0.19 0.19 0.16 0.21 0.19 0.15 0.17 0.17 0.16 0.16 0.15 0.13
25–64 years . . . . . . . . . . . . . . . . . 0.81 0.80 0.65 0.63 0.59 0.56 0.55 0.54 0.53 0.52 0.51 0.47 0.50 0.46 0.43 0.49
65 years and over . . . . . . . . . . . . . 16.82 16.96 16.61 15.45 15.52 16.07 16.06 15.89 15.96 16.00 15.46 16.35 16.74 16.50 15.92 16.15
Chronic liver disease and cirrhosis
(571)
0–24 years . . . . . . . . . . . . . . . . . . 0.16 0.19 0.17 0.15 0.12 0.13 0.10 0.11 0.11 0.09 0.10 0.08 0.07 0.07 0.08 0.06
25–64 years . . . . . . . . . . . . . . . . . 19.52 19.47 17.70 16.14 15.49 14.88 14.29 13.47 13.34 13.23 12.80 12.08 11.60 11.26 11.19 11.21
65 years and over . . . . . . . . . . . . . 35.64 37.26 37.03 35.38 34.69 35.58 34.48 34.07 33.19 33.00 34.34 33.51 32.76 32.43 31.51 31.18
Cholelithiasis and other disorders of
gallbladder (574–575)
0–24 years . . . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.02
25–64 years . . . . . . . . . . . . . . . . . 0.48 0.48 0.41 0.38 0.40 0.37 0.35 0.29 0.31 0.31 0.30 0.27 0.27 0.28 0.25 0.28
65 years and over . . . . . . . . . . . . . 10.44 10.77 10.00 9.34 9.22 9.25 8.97 8.95 8.92 9.05 8.67 8.58 7.93 7.86 7.36 7.42
Nephritis, nephrotic syndrome, and
nephrosis (580–589)
0–24 years . . . . . . . . . . . . . . . . . . 0.46 0.42 0.46 0.43 0.40 0.45 0.44 0.43 0.37 0.38 0.33 0.28 0.32 0.31 0.30 0.26
25–64 years . . . . . . . . . . . . . . . . . 3.15 3.16 2.97 2.98 2.94 2.93 3.01 2.93 2.84 2.91 2.63 2.53 2.41 2.42 2.49 2.29
65 years and over . . . . . . . . . . . . . 47.62 50.76 51.81 53.61 55.81 58.48 61.21 61.54 61.60 61.26 57.07 55.68 56.57 57.97 60.24 59.31
Acute glomerulonephritis and
nephrotic syndrome (580–581)
0–24 years . . . . . . . . . . . . . . . . 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.01
25–64 years . . . . . . . . . . . . . . . . 0.06 0.07 0.05 0.07 0.06 0.06 0.07 0.05 0.04 0.05 0.05 0.05 0.05 0.04 0.04 0.04
65 years and over . . . . . . . . . . . . 0.97 0.88 0.86 0.82 0.98 0.84 0.88 0.73 0.69 0.78 0.75 0.69 0.77 0.71 0.67 0.74
Chronic glomerulonephritis, nephritis
and nephropathy, not specified as
acute or chronic, and renal
sclerosis, unspecified (582–583,587)
0–24 years . . . . . . . . . . . . . . . . . 0.06 0.04 0.04 0.04 0.04 0.03 0.02 0.03 0.03 0.02 0.03 0.02 0.03 0.02 0.02 0.01
25–64 years . . . . . . . . . . . . . . . . 0.51 0.46 0.40 0.37 0.33 0.33 0.25 0.25 0.23 0.24 0.24 0.25 0.21 0.20 0.20 0.19
65 years and over . . . . . . . . . . . . . 7.06 6.72 6.00 5.57 5.40 5.08 4.43 4.07 4.05 4.01 3.87 3.82 3.83 3.80 3.98 3.87
Renal failure, disorders resulting from
impaired renal function, and small
kidney of unknown cause
(584–586,588–589)
0–24 years . . . . . . . . . . . . . . . . . 0.38 0.36 0.40 0.38 0.34 0.41 0.40 0.38 0.33 0.34 0.29 0.23 0.27 0.27 0.26 0.24
25–64 years . . . . . . . . . . . . . . . . 2.58 2.63 2.51 2.54 2.56 2.55 2.70 2.64 2.56 2.62 2.34 2.24 2.16 2.18 2.25 2.06
65 years and over . . . . . . . . . . . . . 39.60 43.16 44.95 47.22 49.44 52.57 55.90 56.73 56.85 56.47 52.45 51.17 51.96 53.47 55.58 54.70
Infections of kidney (590)
0–24 years . . . . . . . . . . . . . . . . . . 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.03 0.01 0.01 0.01
25–64 years . . . . . . . . . . . . . . . . . 0.36 0.33 0.28 0.25 0.23 0.24 0.19 0.19 0.17 0.16 0.14 0.14 0.13 0.11 0.12 0.10
65 years and over . . . . . . . . . . . . . . 9.79 9.23 7.55 7.16 6.60 6.40 6.14 5.62 5.14 4.62 3.97 3.54 3.25 2.87 2.62 2.49











Table 2. Unadjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age ca tegories: United States,
1979–94—Con.
[Rates are per 100,000 population in specified age group]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Hyperplasia of prostate (600)
0–24 years . . . . . . . . . . . . . . . . . . – – – – – – – – – – – – – – – –
25–64 years . . . . . . . . . . . . . . . . . 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01
65 years and over . . . . . . . . . . . . . 3.11 2.83 2.54 2.36 2.00 1.83 1.62 1.67 1.52 1.42 1.40 1.41 1.31 1.21 1.20 1.19
Complications of pregnancy,
childbirth, and the puerperium
(630–676)
0–24 years . . . . . . . . . . . . . . . . . . 0.13 0.12 0.13 0.09 0.12 0.09 0.10 0.10 0.08 0.12 0.11 0.12 0.11 0.12 0.09 0.12
25–64 years . . . . . . . . . . . . . . . . . 0.20 0.21 0.17 0.18 0.15 0.18 0.17 0.15 0.14 0.18 0.18 0.19 0.17 0.16 0.16 0.16
65 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pregnancy with abortive outcome
(630–638)
0–24 years . . . . . . . . . . . . . . . . 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.03 0.02 0.02 0.02 0.02 0.02 0.01
25–64 years . . . . . . . . . . . . . . . . 0.03 0.04 0.03 0.03 0.03 0.03 0.02 0.03 0.03 0.03 0.02 0.03 0.03 0.03 0.02 0.02
65 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other complications of pregnancy,
childbirth, and the puerperium
(640–676)
0–24 years . . . . . . . . . . . . . . . . 0.10 0.10 0.11 0.07 0.10 0.06 0.08 0.08 0.07 0.10 0.09 0.10 0.09 0.10 0.07 0.11
25–64 years . . . . . . . . . . . . . . . . 0.17 0.17 0.14 0.15 0.13 0.15 0.15 0.12 0.12 0.15 0.15 0.16 0.15 0.13 0.14 0.14
65 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Congenital anomalies (740–759)
0–24 years . . . . . . . . . . . . . . . . . . 11.82 12.16 11.84 12.01 11.54 11.41 11.29 11.07 10.75 11.07 11.04 11.11 10.37 9.99 9.58 9.07
25–64 years . . . . . . . . . . . . . . . . . 1.55 1.58 1.45 1.39 1.38 1.41 1.29 1.28 1.31 1.33 1.36 1.34 1.34 1.38 1.43 1.42
65 years and over . . . . . . . . . . . . . 3.12 3.27 3.27 3.28 3.38 3.23 3.24 3.47 3.32 3.57 3.85 4.13 4.33 4.61 5.09 5.04
Certain conditions originating in the
perinatal period (760–779)
0–24 years . . . . . . . . . . . . . . . . . . 24.93 24.37 23.12 22.35 20.86 20.51 21.01 20.17 20.07 20.08 20.67 19.42 18.32 17.05 16.25 15.51
25–64 years . . . . . . . . . . . . . . . . . 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
65 years and over . . . . . . . . . . . . . 0.01 0.01 0.01 0.01 0.01 – 0.00 0.01 0.01 0.01 0.01 0.02 0.00 0.02 0.02 0.01
Birth trauma, intrauterine hypoxia,
birth asphyxia, and respiratory
distress syndrome (767–769)
0–24 years . . . . . . . . . . . . . . . . 8.53 8.08 7.14 6.64 5.80 5.61 5.70 5.15 4.79 4.65 5.10 4.25 3.73 3.17 2.81 2.54
25–64 years . . . . . . . . . . . . . . . . 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.01
65 years and over . . . . . . . . . . . . – – – 0.00 – – – – – – 0.00 – – 0.00 0.01 0.01
Other conditions originating in the
perinatal period (760–766,770–779)
0–24 years . . . . . . . . . . . . . . . . 16.40 16.29 15.98 15.71 15.05 14.90 15.31 15.03 15.27 15.43 15.57 15.17 14.59 13.88 13.43 12.97
25–64 years . . . . . . . . . . . . . . . . 0.01 0.01 0.00 0.00 0.01 0.01 0.00 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.01
65 years and over . . . . . . . . . . . . 0.01 0.01 0.01 0.00 0.01 – 0.00 0.01 0.01 0.01 0.01 0.02 0.00 0.02 0.01 0.01
Symptoms, signs, and ill-defined
conditions (780–799)
0–24 years . . . . . . . . . . . . . . . . . . 7.63 7.90 7.82 7.86 7.70 7.57 7.74 8.09 8.24 8.61 8.64 8.27 8.09 7.45 7.29 6.43
25–64 years . . . . . . . . . . . . . . . . . 7.32 7.37 7.56 7.64 6.83 6.66 6.96 7.05 7.50 6.89 6.14 5.33 5.13 4.67 5.55 5.02
65 years and over . . . . . . . . . . . . . 50.15 52.56 52.61 51.84 53.53 53.71 54.80 53.33 49.13 48.25 37.02 31.46 32.26 32.24 37.74 37.58











Table 2. Unadjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age ca tegories: United States,
1979–94—Con.
[Rates are per 100,000 population in specified age group]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
All other diseases (Residual)
0–24 years . . . . . . . . . . . . . . . . . . 7.38 7.33 7.01 6.61 6.68 6.50 6.43 6.36 5.87 5.86 6.07 5.82 5.88 5.58 5.61 5.24
25–64 years . . . . . . . . . . . . . . . . . 31.03 31.51 30.43 28.84 29.75 29.74 31.85 33.61 28.75 29.21 28.28 27.62 27.66 27.35 27.93 28.23
65 years and over . . . . . . . . . . . . . 269.33 291.99 296.72 304.54 328.85 347.95 373.66 385.82 405.96 419.77 425.21 426.56 430.86 433.77 468.12 486.24
Accidents and adverse effects (E800–E949)
0–24 years . . . . . . . . . . . . . . . . . . 39.08 38.29 34.86 32.18 30.36 30.07 29.67 30.79 29.49 29.27 27.15 25.74 24.65 22.08 22.55 22.31
25–64 years . . . . . . . . . . . . . . . . . 42.11 41.84 40.32 36.68 35.49 35.15 34.91 34.93 34.69 35.11 34.63 33.35 31.20 30.37 31.54 31.52
65 years and over . . . . . . . . . . . . . 95.63 97.24 90.55 85.95 87.18 87.49 87.87 86.65 87.21 89.62 87.46 84.34 83.28 82.52 84.78 85.39
Motor vehicle accidents (E810–E825)
0–24 years . . . . . . . . . . . . . . . . 25.33 24.75 22.68 20.36 19.21 19.73 19.44 20.60 19.87 19.92 18.13 17.38 16.12 14.36 14.60 14.82
25–64 years . . . . . . . . . . . . . . . . 22.57 22.53 22.10 19.08 18.44 18.96 18.58 18.86 19.22 19.25 19.01 18.75 16.83 15.81 15.88 15.73
65 years and over . . . . . . . . . . . . 23.43 22.61 22.42 20.45 20.64 21.89 21.66 22.10 22.89 23.77 23.63 23.20 22.18 21.85 22.34 22.93
All other accidents and adverse
effects (E800–807, E826–E949)
0–24 years . . . . . . . . . . . . . . . . 13.75 13.54 12.18 11.82 11.15 10.35 10.24 10.19 9.62 9.35 9.02 8.36 8.54 7.72 7.95 7.49
25–64 years . . . . . . . . . . . . . . . . 19.54 19.31 18.22 17.60 17.05 16.19 16.33 16.07 15.47 15.86 15.63 14.59 14.37 14.55 15.67 15.79
65 years and over . . . . . . . . . . . . 72.21 74.62 68.13 65.51 66.53 65.60 66.21 64.55 64.33 65.86 63.82 61.14 61.10 60.67 62.44 62.46
Suicide (E950–E959)
0–24 years . . . . . . . . . . . . . . . . . . 5.75 5.74 5.70 5.62 5.46 5.72 5.90 5.90 5.70 5.71 5.64 5.65 5.48 5.44 5.57 5.66
25–64 years . . . . . . . . . . . . . . . . . 16.19 15.79 16.18 16.16 15.75 15.94 15.48 16.03 15.70 15.23 15.04 15.28 15.13 14.77 14.90 14.81
65 years and over . . . . . . . . . . . . . 18.71 17.76 17.08 18.36 19.31 19.79 20.37 21.63 21.82 21.12 20.30 20.57 19.74 19.09 18.94 18.12
Homicide and legal intervention
(E960–E978)
0–24 years . . . . . . . . . . . . . . . . . . 7.49 8.09 7.67 7.23 6.39 6.34 6.27 7.20 7.02 7.64 8.19 9.44 10.36 10.16 10.66 10.16
25–64 years . . . . . . . . . . . . . . . . . 13.39 14.17 13.76 12.74 11.39 10.97 10.91 11.48 10.89 11.05 11.25 11.84 12.13 11.36 11.23 10.64
65 years and over . . . . . . . . . . . . . 5.21 5.55 5.00 4.93 4.54 4.27 4.30 4.50 4.59 4.42 4.17 4.03 4.11 3.81 3.69 3.46
All other external causes (E980–E999)
0–24 years . . . . . . . . . . . . . . . . . . 1.13 1.02 0.96 0.82 0.77 0.75 0.63 0.68 0.68 0.68 0.55 0.49 0.50 0.50 0.62 0.63
25–64 years . . . . . . . . . . . . . . . . . 2.24 2.10 2.03 1.83 1.74 1.65 1.61 1.76 1.66 1.64 1.51 1.32 1.36 1.65 1.92 1.90
65 years and over . . . . . . . . . . . . . 1.74 1.80 1.86 1.38 1.46 1.43 1.20 1.24 1.21 1.20 0.91 0.82 0.83 0.79 0.88 0.84
Human immunodeficiency virus
infection1 (*042–*044)
0–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.80 0.87 1.00 0.94 1.05 1.02 1.14 1.20
25–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.19 12.47 16.53 18.83 21.75 24.48 26.89 30.10
65 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.07 1.25 1.33 1.44 1.73 1.92 1.97 2.09
Alzheimer’s disease2 (331.0)
0–24 years . . . . . . . . . . . . . . . . . . – – – 0.00 – 0.00 0.00 – – – – 0.00 – – 0.00 0.00
25–64 years . . . . . . . . . . . . . . . . . 0.19 0.26 0.26 0.33 0.35 0.35 0.37 0.37 0.36 0.35 0.30 0.28 0.27 0.23 0.25 0.27
65 years and over . . . . . . . . . . . . . 2.60 4.06 5.62 8.44 14.76 20.97 27.52 30.96 36.71 39.31 41.51 43.08 43.36 43.80 50.11 54.94
0.0 Quantity more than zero but less than 0.05.
. . . Category not applicable.
– Quantity zero.
* Beginning with data year 1987, the National Center for Health Statistics introduced categories *042–*044 for classifying and coding Human immunodeficiency virus infection. The asterisks indicate that these categories are not part of the Ninth Revision,
International Classification of Diseases, 1975.
1Included in All other infectious and parasitic diseases shown above.











Table 3. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age categories: United States
1979–94
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
All causes
0–24 years . . . . . . . . . . . . . . . . . . 117.60 115.89 108.21 103.54 98.63 98.10 96.73 97.95 95.94 96.82 95.10 92.72 91.07 86.32 87.67 85.61
25–64 years . . . . . . . . . . . . . . . . . 461.49 461.73 452.39 437.54 432.52 428.80 428.85 426.62 423.99 423.18 417.49 411.52 408.18 401.24 406.03 403.40
65 years and over . . . . . . . . . . . . . 4,317.87 4,454.11 4,320.12 4,255.26 4,290.10 4,256.68 4,275.51 4,224.95 4,175.46 4,185.91 4,064.64 4,009.74 3,949.97 3,894.69 3,979.69 3,926.32
Shigellosis and amebiasis (004,006)
0–24 years . . . . . . . . . . . . . . . . . . 0.02 0.01 0.01 0.00 0.01 0.00 0.01 0.00 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.00
25–64 years . . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.00 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00
65 years and over . . . . . . . . . . . . . 0.04 0.04 0.04 0.02 0.05 0.03 0.04 0.01 0.02 0.01 0.02 0.02 0.01 0.02 0.02 0.01
Certain other intestinal infections
(007–009)
0–24 years . . . . . . . . . . . . . . . . . . 0.14 0.15 0.17 0.16 0.15 0.16 0.12 0.13 0.11 0.10 0.11 0.11 0.13 0.14 0.14 0.22
25–64 years . . . . . . . . . . . . . . . . . 0.04 0.05 0.04 0.04 0.04 0.04 0.04 0.06 0.04 0.03 0.03 0.04 0.04 0.04 0.05 0.06
65 years and over . . . . . . . . . . . . . 0.40 0.50 0.47 0.35 0.43 0.34 0.38 0.36 0.39 0.43 0.46 0.57 0.60 0.71 0.92 0.92
Tuberculosis (010–018)
0–24 years . . . . . . . . . . . . . . . . . . 0.03 0.02 0.03 0.02 0.03 0.04 0.04 0.03 0.03 0.04 0.04 0.04 0.03 0.03 0.02 0.02
25–64 years . . . . . . . . . . . . . . . . . 0.75 0.68 0.69 0.59 0.59 0.60 0.59 0.63 0.60 0.63 0.65 0.62 0.58 0.54 0.49 0.43
65 years and over . . . . . . . . . . . . . 4.13 4.27 3.88 3.63 3.47 3.18 3.15 3.00 2.97 3.17 3.21 2.80 2.53 2.63 2.55 2.26
Tuberculosis of respiratory system
(010–012)
0–24 years . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.01 0.02 0.01 0.02 0.02 0.02 0.01 0.00 0.01
25–64 years . . . . . . . . . . . . . . . . 0.62 0.55 0.56 0.47 0.46 0.45 0.45 0.47 0.45 0.47 0.48 0.44 0.44 0.40 0.37 0.30
65 years and over . . . . . . . . . . . . 3.46 3.59 3.25 3.02 2.82 2.55 2.54 2.47 2.45 2.56 2.60 2.28 1.98 2.11 2.07 1.79
Other tuberculosis (013–018)
0–24 years . . . . . . . . . . . . . . . . 0.02 0.02 0.02 0.01 0.01 0.02 0.02 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.01
25–64 years . . . . . . . . . . . . . . . . 0.13 0.13 0.13 0.12 0.13 0.15 0.14 0.16 0.14 0.16 0.17 0.19 0.14 0.14 0.12 0.13
65 years and over . . . . . . . . . . . . 0.67 0.68 0.63 0.62 0.64 0.64 0.62 0.54 0.52 0.61 0.61 0.52 0.56 0.52 0.47 0.47
Whooping cough (033)
0–24 years . . . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.01 0.01 – 0.00 0.01 0.01
25–64 years . . . . . . . . . . . . . . . . . – – – – – – – – – – – – – – – –
65 years and over . . . . . . . . . . . . . – – – – – – – 0.00 – – – – – – – –
Streptococcal sore throat, scarlatina,
and erysipelas (034–035)
0–24 years . . . . . . . . . . . . . . . . . . 0.01 0.00 0.00 0.00 – – – 0.00 0.00 0.00 0.00 0.00 – – 0.00 0.00
25–64 years . . . . . . . . . . . . . . . . . 0.01 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.01
65 years and over . . . . . . . . . . . . . 0.03 0.02 0.03 0.02 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.02 0.01 0.01 0.01 0.01
Meningococcal infection (036)
0–24 years . . . . . . . . . . . . . . . . . . 0.29 0.28 0.32 0.25 0.21 0.21 0.18 0.19 0.18 0.19 0.18 0.14 0.14 0.13 0.16 0.18
25–64 years . . . . . . . . . . . . . . . . . 0.09 0.08 0.09 0.07 0.05 0.06 0.05 0.06 0.05 0.06 0.05 0.04 0.03 0.03 0.05 0.05
65 years and over . . . . . . . . . . . . . 0.15 0.16 0.19 0.15 0.13 0.11 0.11 0.11 0.07 0.08 0.12 0.08 0.07 0.07 0.09 0.09
Septicemia (038)
0–24 years . . . . . . . . . . . . . . . . . . 0.47 0.45 0.51 0.46 0.51 0.53 0.53 0.53 0.51 0.49 0.50 0.49 0.46 0.42 0.44 0.43
25–64 years . . . . . . . . . . . . . . . . . 1.64 1.85 2.04 2.08 2.25 2.50 2.65 2.81 2.88 2.88 2.73 2.65 2.62 2.61 2.56 2.63
65 years and over . . . . . . . . . . . . . 19.09 22.20 23.57 25.94 29.87 32.85 37.29 39.80 41.74 43.09 37.88 37.42 37.51 36.92 37.99 36.45
Acute poliomyelitis (045)
0–24 years . . . . . . . . . . . . . . . . . . – – – – – – – – – 0.00 – – – – – –
25–64 years . . . . . . . . . . . . . . . . . 0.00 0.00 – – – – 0.00 – – – – – 0.00 – – –
65 years and over . . . . . . . . . . . . . – 0.01 – – – – 0.01 – – – – – – – – –











Table 3. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age categories: United States
1979–94—Con.
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Measles (055)
0–24 years . . . . . . . . . . . . . . . . . . 0.00 0.01 0.00 0.00 0.00 – 0.00 0.00 0.00 0.00 0.03 0.05 0.02 0.00 – –
25–64 years . . . . . . . . . . . . . . . . . 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 – –
65 years and over . . . . . . . . . . . . . – – – – – – – – – – 0.00 – – – – –
Viral hepatitis (070)
0–24 years . . . . . . . . . . . . . . . . . . 0.11 0.11 0.11 0.09 0.12 0.10 0.09 0.08 0.08 0.05 0.08 0.05 0.05 0.04 0.05 0.04
25–64 years . . . . . . . . . . . . . . . . . 0.35 0.36 0.42 0.36 0.37 0.40 0.41 0.42 0.51 0.55 0.61 0.62 0.78 0.83 1.06 1.26
65 years and over . . . . . . . . . . . . . 0.99 1.11 1.03 1.11 1.16 1.08 1.31 1.43 1.64 1.85 2.18 2.38 2.50 2.69 3.17 3.93
Syphilis (090–097)
0–24 years . . . . . . . . . . . . . . . . . . 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.00 0.02 0.02 0.02 0.03 0.03 0.02 0.01 0.01
25–64 years . . . . . . . . . . . . . . . . . 0.03 0.02 0.03 0.02 0.02 0.01 0.02 0.01 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.01
65 years and over . . . . . . . . . . . . . 0.47 0.44 0.33 0.27 0.29 0.25 0.15 0.18 0.17 0.12 0.14 0.12 0.11 0.12 0.10 0.13




0–24 years . . . . . . . . . . . . . . . . . . 0.65 0.61 0.57 0.61 0.58 0.62 0.66 0.75 1.41 1.50 1.64 1.60 1.66 1.62 1.80 1.85
25–64 years . . . . . . . . . . . . . . . . . 1.30 1.36 1.49 1.54 1.85 2.56 3.40 4.61 12.25 14.67 18.87 21.06 23.81 26.44 28.76 31.91
65 years and over . . . . . . . . . . . . . 5.65 6.90 6.91 7.30 7.55 8.11 8.85 9.46 9.99 10.90 11.44 11.10 10.71 10.81 11.27 11.27
Malignant neoplasms, including
neoplasms of lymphatic and
hematopoietic tissues (140–208)
0–24 years . . . . . . . . . . . . . . . . . . 5.09 5.13 4.80 4.93 4.72 4.40 4.32 4.31 4.09 4.00 4.01 3.90 3.90 3.85 3.76 3.68
25–64 years . . . . . . . . . . . . . . . . . 129.60 130.58 129.32 129.61 129.22 130.30 130.28 128.53 128.05 127.43 126.27 125.94 124.72 121.69 119.96 117.94
65 years and over . . . . . . . . . . . . . 932.37 953.97 949.75 962.26 970.61 979.43 984.27 994.34 996.44 1,001.33 1,017.43 1,028.21 1,029.31 1,030.96 1,037.78 1,036.61
Malignant neoplasms of lip, oral
cavity, and pharynx (140–149)
0–24 years . . . . . . . . . . . . . . . . 0.04 0.03 0.04 0.05 0.04 0.03 0.03 0.04 0.02 0.04 0.04 0.03 0.03 0.03 0.03 0.03
25–64 years . . . . . . . . . . . . . . . . 3.58 3.48 3.36 3.29 3.25 3.22 3.02 2.98 2.84 2.88 2.84 2.78 2.74 2.59 2.62 2.42
65 years and over . . . . . . . . . . . . 17.02 16.94 16.79 16.51 16.11 15.88 15.85 15.47 14.70 14.95 14.39 15.17 14.54 14.21 14.09 13.50
Malignant neoplasms of digestive
organs and peritoneum (150–159)
0–24 years . . . . . . . . . . . . . . . . 0.21 0.25 0.22 0.25 0.21 0.19 0.21 0.18 0.19 0.17 0.18 0.17 0.19 0.20 0.19 0.20
25–64 years . . . . . . . . . . . . . . . . 28.13 27.72 27.37 27.15 26.94 27.19 26.81 26.19 26.10 25.52 25.11 25.22 25.13 24.66 24.51 24.33
65 years and over . . . . . . . . . . . . 277.28 277.84 273.06 270.87 268.95 270.73 266.16 262.71 259.28 255.48 258.13 256.58 251.97 250.72 250.26 248.63
Malignant neoplasms of respiratory
and intrathoracic organs (160–165)
0–24 years . . . . . . . . . . . . . . . . 0.08 0.09 0.07 0.09 0.10 0.10 0.08 0.06 0.06 0.07 0.07 0.07 0.07 0.07 0.06 0.06
25–64 years . . . . . . . . . . . . . . . . 38.86 39.48 39.71 40.23 40.14 40.57 40.74 40.37 40.77 40.70 40.39 40.57 39.51 38.47 37.74 36.36
65 years and over . . . . . . . . . . . . 230.38 242.82 245.12 254.77 261.86 267.03 273.24 279.22 286.93 291.60 300.39 307.87 311.94 315.19 319.53 320.31
Malignant neoplasm of breast (174–175)
0–24 years . . . . . . . . . . . . . . . . 0.02 0.02 0.02 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.02 0.02
25–64 years . . . . . . . . . . . . . . . . 15.66 15.93 15.73 15.72 15.58 15.87 15.95 15.67 15.59 15.65 15.32 15.23 14.98 14.18 13.82 13.57
65 years and over . . . . . . . . . . . . 64.21 65.88 67.49 68.18 68.48 70.48 70.45 71.10 70.69 72.10 73.47 73.75 72.27 71.61 71.23 70.70











Table 3. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age categories: United States
1979–94—Con.
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Malignant neoplasms of genital
organs (179–187)
0–24 years . . . . . . . . . . . . . . . . 0.22 0.24 0.20 0.20 0.23 0.18 0.17 0.15 0.14 0.14 0.14 0.13 0.12 0.12 0.13 0.12
25–64 years . . . . . . . . . . . . . . . . 10.97 10.88 10.66 10.38 10.25 10.06 9.95 9.94 9.62 9.60 9.61 9.75 9.56 9.42 9.06 9.09
65 years and over . . . . . . . . . . . . 117.12 118.00 116.19 116.77 118.12 116.60 117.33 119.45 119.27 121.16 122.55 127.23 127.52 127.70 125.69 125.04
Malignant neoplasms of urinary
organs (188–189)
0–24 years . . . . . . . . . . . . . . . . 0.14 0.12 0.12 0.11 0.13 0.09 0.09 0.10 0.09 0.11 0.09 0.08 0.09 0.08 0.07 0.08
25–64 years . . . . . . . . . . . . . . . . 4.13 4.08 4.04 4.14 4.02 3.99 4.05 4.04 4.06 3.91 4.06 4.08 4.12 4.07 4.00 3.96
65 years and over . . . . . . . . . . . . 45.00 45.76 44.80 45.02 44.42 43.78 43.57 43.16 43.06 43.06 43.71 43.90 44.18 44.24 44.27 45.10
Malignant neoplasms of all other and
unspecified sites (170–173,190–199)
0–24 years . . . . . . . . . . . . . . . . 2.03 2.05 1.96 2.02 1.91 1.84 1.82 1.82 1.75 1.73 1.75 1.73 1.71 1.67 1.70 1.65
25–64 years . . . . . . . . . . . . . . . . 17.25 17.68 17.62 17.70 18.02 18.17 18.58 18.35 18.29 18.22 17.72 17.15 17.39 17.11 17.16 16.90
65 years and over . . . . . . . . . . . . 101.12 104.34 104.86 106.17 107.81 109.74 110.36 113.81 114.52 114.01 112.68 110.32 111.47 111.74 115.37 114.95
Leukemia (204–208)
0–24 years . . . . . . . . . . . . . . . . 1.75 1.72 1.56 1.60 1.48 1.41 1.36 1.36 1.34 1.26 1.25 1.23 1.21 1.22 1.16 1.14
25–64 years . . . . . . . . . . . . . . . . 4.40 4.57 4.33 4.26 4.33 4.40 4.28 4.19 4.11 4.07 4.17 4.15 4.06 4.08 4.03 3.95
65 years and over . . . . . . . . . . . . 33.73 34.28 33.73 34.14 33.70 33.74 34.11 33.72 32.89 33.29 34.52 34.75 35.05 34.90 35.07 34.91
Other malignant neoplasms of lymphatic
and hematopoietic tissues (200–203)
0–24 years . . . . . . . . . . . . . . . . 0.60 0.62 0.62 0.58 0.58 0.54 0.54 0.57 0.49 0.47 0.48 0.44 0.47 0.45 0.40 0.38
25–64 years . . . . . . . . . . . . . . . . 6.61 6.75 6.51 6.74 6.69 6.84 6.89 6.80 6.68 6.88 7.04 7.02 7.23 7.12 7.02 7.36
65 years and over . . . . . . . . . . . . 46.51 48.11 47.72 49.82 51.15 51.45 53.20 55.70 55.10 55.67 57.58 58.64 60.36 60.66 62.29 63.47
Benign neoplasms, carcinoma in situ,
and neoplasms of uncertain
behavior and of unspecified nature
(210–239)
0–24 years . . . . . . . . . . . . . . . . . . 0.34 0.36 0.33 0.36 0.34 0.33 0.34 0.38 0.32 0.36 0.31 0.36 0.33 0.34 0.32 0.37
25–64 years . . . . . . . . . . . . . . . . . 1.76 1.80 1.65 1.67 1.57 1.44 1.53 1.50 1.34 1.40 1.35 1.33 1.31 1.33 1.39 1.38
65 years and over . . . . . . . . . . . . . 12.95 13.38 13.72 13.79 13.66 13.67 13.77 13.33 13.39 13.07 12.87 12.68 12.99 12.71 13.02 12.64
Diabetes mellitus (250)
0–24 years . . . . . . . . . . . . . . . . . . 0.23 0.19 0.20 0.21 0.19 0.16 0.18 0.19 0.18 0.18 0.21 0.17 0.19 0.19 0.18 0.17
25–64 years . . . . . . . . . . . . . . . . . 7.73 8.03 7.82 7.64 7.97 7.54 7.76 7.95 8.13 8.63 9.53 9.61 9.75 9.84 10.21 10.60
65 years and over . . . . . . . . . . . . . 84.81 87.97 84.95 82.93 85.15 82.79 83.55 81.69 83.43 84.96 98.61 99.02 99.71 99.89 106.19 110.32
Nutritional deficiencies (260–269)
0–24 years . . . . . . . . . . . . . . . . . . 0.06 0.05 0.05 0.05 0.05 0.03 0.04 0.03 0.05 0.04 0.03 0.03 0.03 0.04 0.03 0.03
25–64 years . . . . . . . . . . . . . . . . . 0.25 0.22 0.21 0.17 0.18 0.17 0.19 0.18 0.16 0.17 0.17 0.17 0.15 0.17 0.17 0.16
65 years and over . . . . . . . . . . . . . 5.40 5.80 5.49 5.70 5.97 5.73 6.09 5.95 5.83 5.87 5.82 5.64 5.44 5.47 5.95 5.72
Anemias (280–285)
0–24 years . . . . . . . . . . . . . . . . . . 0.36 0.32 0.29 0.31 0.32 0.31 0.27 0.28 0.25 0.25 0.27 0.28 0.24 0.32 0.28 0.26
25–64 years . . . . . . . . . . . . . . . . . 0.60 0.59 0.58 0.53 0.58 0.53 0.58 0.53 0.61 0.55 0.63 0.64 0.62 0.63 0.61 0.67
65 years and over . . . . . . . . . . . . . 6.86 7.05 7.14 6.91 7.01 7.07 7.19 7.10 6.99 6.95 7.02 6.94 6.87 6.78 6.73 6.67
Meningitis (320–322)
0–24 years . . . . . . . . . . . . . . . . . . 0.76 0.81 0.70 0.61 0.60 0.54 0.49 0.42 0.42 0.42 0.36 0.33 0.22 0.21 0.20 0.21
25–64 years . . . . . . . . . . . . . . . . . 0.32 0.28 0.34 0.29 0.28 0.26 0.26 0.28 0.31 0.25 0.28 0.27 0.23 0.22 0.21 0.22
65 years and over . . . . . . . . . . . . . 1.27 1.25 1.18 1.18 1.26 1.13 1.32 1.25 1.12 1.30 1.04 0.98 1.01 0.81 0.85 0.72











Table 3. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age categories: United States
1979–94—Con.
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Major cardiovascular diseases
(390–448)
0–24 years . . . . . . . . . . . . . . . . . . 3.34 3.70 3.37 3.38 3.57 3.63 3.51 3.52 3.44 3.46 3.04 3.05 3.08 2.98 3.06 3.07
25–64 years . . . . . . . . . . . . . . . . . 165.46 162.60 158.80 152.89 150.28 146.01 142.63 137.93 133.79 129.66 122.87 118.41 115.91 113.26 113.03 110.20
65 years and over . . . . . . . . . . . . . 2,483.59 2,528.34 2,410.60 2,350.23 2,326.22 2,259.46 2,222.92 2,154.85 2,098.37 2,073.55 1,948.98 1,888.89 1,836.03 1,788.53 1,810.03 1,757.79
Diseases of heart (390–398,402,404–429)
0–24 years . . . . . . . . . . . . . . . . 2.46 2.79 2.58 2.63 2.77 2.85 2.76 2.86 2.77 2.76 2.39 2.39 2.40 2.34 2.35 2.40
25–64 years . . . . . . . . . . . . . . . . 139.16 137.08 134.11 129.58 127.43 123.48 120.83 116.59 112.67 108.94 102.81 98.72 96.63 94.24 93.97 91.22
65 years and over . . . . . . . . . . . . 1,883.20 1,932.09 1,856.46 1,825.65 1,821.19 1,771.67 1,749.29 1,700.87 1,654.39 1,636.10 1,534.94 1,484.68 1,444.52 1,405.28 1,420.77 1,369.23
Rheumatic fever and rheumatic heart
disease (390–398)
0–24 years . . . . . . . . . . . . . . . . 0.10 0.12 0.08 0.09 0.08 0.10 0.09 0.07 0.07 0.08 0.06 0.06 0.04 0.06 0.05 0.07
25–64 years . . . . . . . . . . . . . . . . 2.73 2.63 2.32 2.08 2.08 1.89 1.76 1.63 1.50 1.43 1.31 1.27 1.19 1.13 1.07 0.99
65 years and over . . . . . . . . . . . . 17.56 17.64 16.72 15.90 14.77 15.13 14.16 13.74 13.70 13.58 12.65 12.27 11.94 11.19 11.14 10.40
Hypertensive heart disease (402)
0–24 years . . . . . . . . . . . . . . . 0.02 0.02 0.02 0.02 0.01 0.02 0.03 0.02 0.02 0.03 0.02 0.02 0.03 0.03 0.02 0.03
25–64 years . . . . . . . . . . . . . . 4.92 4.66 4.74 4.49 4.52 4.33 4.36 4.19 4.25 4.15 4.15 4.02 4.04 4.15 4.15 4.34
65 years and over . . . . . . . . . . . 52.21 52.10 49.15 48.59 47.87 46.33 45.26 43.62 42.89 42.21 41.20 40.99 39.93 39.76 40.96 40.90
Hypertensive heart and renal
disease(404)
0–24 years . . . . . . . . . . . . . . . 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.01 0.00
25–64 years . . . . . . . . . . . . . . 0.39 0.40 0.34 0.29 0.29 0.26 0.31 0.28 0.30 0.28 0.25 0.30 0.28 0.28 0.27 0.27
65 years and over . . . . . . . . . . . 9.93 9.79 8.64 7.56 7.50 6.99 6.44 5.63 5.49 5.23 5.07 4.93 4.93 4.84 4.71 4.67
Ischemic heart disease (410–414)
0–24 years . . . . . . . . . . . . . . . 0.19 0.21 0.23 0.24 0.23 0.25 0.19 0.18 0.19 0.19 0.17 0.18 0.19 0.17 0.19 0.18
25–64 years . . . . . . . . . . . . . . 102.92 100.17 97.08 93.61 89.83 85.90 82.59 77.57 73.93 69.88 66.75 63.91 62.07 59.65 58.43 56.46
65 years and over . . . . . . . . . . . 1,434.80 1,456.07 1,386.78 1,354.32 1,326.15 1,273.06 1,237.34 1,177.57 1,134.17 1,111.64 1,062.83 1,029.95 993.34 961.40 958.52 922.33
Acute myocardial infarction (410)
0–24 years . . . . . . . . . . . . . . 0.13 0.14 0.14 0.15 0.14 0.14 0.12 0.10 0.11 0.11 0.11 0.11 0.10 0.10 0.10 0.10
25–64 years . . . . . . . . . . . . . 70.62 66.80 63.83 61.13 57.74 54.48 51.32 47.14 44.30 41.00 39.44 37.42 36.04 34.33 33.14 31.98
65 years and over . . . . . . . . . 772.46 766.93 730.63 715.90 692.52 663.31 641.38 599.97 571.23 550.95 535.81 510.90 488.40 465.76 451.46 432.62
Other acute and subacute forms
of ischemic heart disease (411)
0–24 years . . . . . . . . . . . . . . 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.00 0.00 0.00
25–64 years . . . . . . . . . . . . . 1.42 1.40 1.33 1.23 1.14 1.06 1.08 1.02 0.88 0.78 0.77 0.83 0.77 0.71 0.64 0.60
65 years and over . . . . . . . . . 10.92 10.83 9.97 8.81 8.64 8.53 8.06 7.76 6.99 6.76 6.49 6.22 6.02 5.67 5.20 4.79
Angina pectoris (413)
0–24 years . . . . . . . . . . . . . . 0.00 – – 0.00 0.00 0.00 0.00 0.00 – – – 0.00 – 0.00 0.00 0.00
25–64 years . . . . . . . . . . . . . 0.09 0.10 0.10 0.11 0.12 0.14 0.13 0.13 0.12 0.10 0.12 0.09 0.10 0.09 0.09 0.09
65 years and over . . . . . . . . . 1.32 1.50 1.43 1.52 1.81 2.01 2.20 2.33 2.33 2.32 2.29 2.31 2.20 1.97 1.84 1.65
Old myocardial infarction and other
forms of chronic ischemic heart
disease (412,414)
0–24 years . . . . . . . . . . . . . . 0.05 0.06 0.08 0.08 0.08 0.10 0.06 0.07 0.08 0.07 0.06 0.07 0.08 0.06 0.09 0.07
25–64 years . . . . . . . . . . . . . 30.79 31.86 31.82 31.14 30.83 30.21 30.07 29.28 28.64 28.00 26.43 25.57 25.16 24.52 24.55 23.79
65 years and over . . . . . . . . . 650.10 676.82 644.76 628.10 623.17 599.20 585.69 567.51 553.62 551.61 518.25 510.52 496.73 488.01 500.02 483.27











Table 3. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age categories: United States
1979–94—Con.
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Other diseases of endocardium (424)
0–24 years . . . . . . . . . . . . . . . 0.09 0.09 0.08 0.09 0.09 0.09 0.10 0.08 0.09 0.07 0.08 0.08 0.09 0.08 0.06 0.07
25–64 years . . . . . . . . . . . . . . 1.30 1.35 1.31 1.29 1.23 1.23 1.29 1.27 1.34 1.33 1.31 1.36 1.25 1.26 1.27 1.23
65 years and over . . . . . . . . . . . 17.02 18.37 18.54 19.15 20.37 20.68 21.91 23.03 23.93 25.39 25.50 26.67 27.18 27.76 28.37 28.35
All other forms of heart disease
(415–423,425–429)
0–24 years . . . . . . . . . . . . . . . 2.06 2.34 2.17 2.18 2.36 2.40 2.34 2.51 2.40 2.38 2.05 2.04 2.05 2.01 2.02 2.05
25–64 years . . . . . . . . . . . . . . 26.90 27.87 28.32 27.83 29.46 29.86 30.52 31.66 31.35 31.87 29.04 27.87 27.79 27.77 28.80 27.92
65 years and over . . . . . . . . . . . 351.67 378.12 376.63 380.13 404.53 409.49 424.18 437.28 434.21 438.05 387.69 369.87 367.19 360.33 377.07 362.58
Hypertension with or without renal
disease (401,403)
0–24 years . . . . . . . . . . . . . . . . 0.03 0.03 0.02 0.02 0.02 0.01 0.02 0.01 0.02 0.01 0.03 0.02 0.02 0.03 0.03 0.03
25–64 years . . . . . . . . . . . . . . . . 1.27 1.33 1.26 1.15 1.16 1.17 1.17 1.16 1.15 1.22 1.20 1.22 1.23 1.25 1.42 1.36
65 years and over . . . . . . . . . . . . 18.38 19.61 18.58 18.35 18.29 18.25 17.61 17.87 17.91 18.03 18.29 18.90 19.22 20.34 21.20 22.10
Cerebrovascular diseases
(430–438)
0–24 years . . . . . . . . . . . . . . . . 0.70 0.75 0.65 0.60 0.64 0.63 0.60 0.51 0.53 0.58 0.51 0.53 0.54 0.49 0.57 0.52
25–64 years . . . . . . . . . . . . . . . . 20.57 19.66 19.18 18.01 17.46 17.21 16.53 16.17 15.96 15.58 14.86 14.63 14.20 14.00 13.90 14.00




0–24 years . . . . . . . . . . . . . . . 0.31 0.32 0.29 0.27 0.28 0.27 0.24 0.21 0.20 0.21 0.20 0.18 0.18 0.17 0.18 0.16
25–64 years . . . . . . . . . . . . . . 5.88 5.66 5.58 5.36 5.10 5.17 5.09 4.98 5.07 5.01 4.84 4.72 4.60 4.58 4.55 4.62




0–24 years . . . . . . . . . . . . . . . 0.06 0.06 0.05 0.05 0.06 0.06 0.05 0.05 0.05 0.06 0.06 0.06 0.07 0.04 0.06 0.07
25–64 years . . . . . . . . . . . . . . 2.66 2.44 2.19 2.02 1.99 1.94 1.78 1.72 1.64 1.52 1.35 1.33 1.21 1.08 1.02 0.97
65 years and over . . . . . . . . . . . 98.90 92.46 81.73 72.08 64.98 60.24 57.57 53.71 49.90 46.40 41.88 37.90 33.64 30.61 29.10 27.52
Cerebral embolism (434.1)
0–24 years . . . . . . . . . . . . . . . 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00 – 0.01 – 0.00 –
25–64 years . . . . . . . . . . . . . . 0.13 0.13 0.12 0.10 0.09 0.09 0.08 0.08 0.09 0.07 0.06 0.06 0.05 0.05 0.06 0.06
65 years and over . . . . . . . . . . . 2.35 2.10 2.14 1.95 1.91 1.96 1.92 1.90 1.69 1.71 1.54 1.45 1.36 1.33 1.26 1.44
All other and late effects of
cerebrovascular diseases
(430,433,435–438)
0–24 years . . . . . . . . . . . . . . . 0.33 0.36 0.31 0.28 0.31 0.30 0.30 0.24 0.28 0.31 0.25 0.29 0.29 0.28 0.33 0.30
25–64 years . . . . . . . . . . . . . . 11.89 11.43 11.29 10.53 10.28 10.00 9.58 9.39 9.17 8.98 8.60 8.52 8.33 8.29 8.27 8.36
65 years and over . . . . . . . . . . . 299.78 304.75 284.90 271.45 263.98 254.98 246.37 235.25 231.56 229.44 218.49 215.07 209.75 205.90 212.22 214.12
Atherosclerosis (440)
0–24 years . . . . . . . . . . . . . . . . 0.00 0.00 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
25–64 years . . . . . . . . . . . . . . . . 1.03 1.10 1.02 1.00 1.01 0.87 0.89 0.89 0.86 0.81 0.74 0.70 0.67 0.65 0.62 0.60
65 years and over . . . . . . . . . . . . 75.15 74.93 68.23 63.49 60.41 54.56 51.91 47.88 46.79 44.75 38.11 35.01 32.81 30.78 30.65 29.86











Table 3. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age categories: United States
1979–94—Con.
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Other diseases of arteries, arterioles, and
capillaries (441–448)
0–24 years . . . . . . . . . . . . . . . . 0.15 0.14 0.12 0.12 0.14 0.12 0.13 0.14 0.12 0.10 0.10 0.11 0.11 0.12 0.12 0.12
25–64 years . . . . . . . . . . . . . . . . 3.43 3.42 3.24 3.15 3.22 3.28 3.21 3.11 3.14 3.12 3.26 3.13 3.18 3.12 3.11 3.02
65 years and over . . . . . . . . . . . . 54.18 54.78 53.82 53.61 53.66 54.66 54.62 54.88 54.48 54.48 55.77 56.04 55.46 54.90 55.37 54.50
Acute bronchitis and bronchiolitis (466)
0–24 years . . . . . . . . . . . . . . . . . . 0.16 0.15 0.13 0.12 0.11 0.10 0.09 0.08 0.10 0.10 0.10 0.10 0.09 0.11 0.09 0.10
25–64 years . . . . . . . . . . . . . . . . . 0.09 0.09 0.08 0.07 0.08 0.07 0.07 0.05 0.06 0.07 0.06 0.06 0.07 0.07 0.07 0.05
65 years and over . . . . . . . . . . . . . 0.99 1.17 1.05 0.83 0.91 0.97 1.10 1.13 0.91 1.07 1.09 1.02 0.98 0.85 1.00 0.85
Pneumonia and influenza (480–487)
0–24 years . . . . . . . . . . . . . . . . . . 2.05 1.89 1.58 1.47 1.43 1.37 1.33 1.31 1.25 1.24 1.26 1.16 1.19 1.09 1.09 1.05
25–64 years . . . . . . . . . . . . . . . . . 5.69 6.29 6.10 5.40 5.55 5.65 6.12 6.27 6.06 6.53 6.32 6.26 6.05 5.51 6.01 5.77
65 years and over . . . . . . . . . . . . . 108.47 130.72 124.48 110.44 123.60 128.56 143.73 145.01 140.51 153.78 147.76 151.91 143.47 137.84 146.02 141.42
Pneumonia (480–486)
0–24 years . . . . . . . . . . . . . . . . 2.01 1.84 1.52 1.45 1.40 1.33 1.30 1.27 1.23 1.21 1.21 1.12 1.13 1.07 1.04 1.03
25–64 years . . . . . . . . . . . . . . . . 5.64 6.13 5.90 5.34 5.46 5.58 6.00 6.16 6.00 6.43 6.20 6.14 5.96 5.44 5.94 5.67
65 years and over . . . . . . . . . . . . 107.03 124.13 117.37 108.88 120.47 126.24 139.51 141.29 139.38 150.07 144.89 147.97 141.54 136.10 144.35 139.39
Influenza (487)
0–24 years . . . . . . . . . . . . . . . . 0.04 0.05 0.05 0.02 0.03 0.03 0.03 0.04 0.02 0.03 0.05 0.04 0.05 0.03 0.05 0.02
25–64 years . . . . . . . . . . . . . . . . 0.05 0.16 0.20 0.06 0.09 0.07 0.12 0.11 0.06 0.10 0.12 0.12 0.09 0.07 0.07 0.09
65 years and over . . . . . . . . . . . . 1.44 6.60 7.11 1.56 3.13 2.32 4.22 3.72 1.13 3.71 2.86 3.94 1.93 1.74 1.67 2.04
Chronic obstructive pulmonary
diseases and allied conditions
(490–496)
0–24 years . . . . . . . . . . . . . . . . . . 0.33 0.35 0.37 0.43 0.41 0.38 0.41 0.42 0.47 0.41 0.43 0.44 0.48 0.43 0.48 0.50
25–64 years . . . . . . . . . . . . . . . . . 9.29 9.81 9.95 9.60 10.26 10.32 10.73 10.64 10.63 10.92 11.04 10.69 10.87 10.42 10.98 10.80
65 years and over . . . . . . . . . . . . . 142.74 159.00 163.58 163.93 177.73 182.07 193.37 195.47 195.03 203.67 202.39 206.43 211.14 211.04 228.81 225.32
Bronchitis, chronic and unspecified
(490–491)
0–24 years . . . . . . . . . . . . . . . . 0.13 0.09 0.10 0.09 0.08 0.07 0.07 0.07 0.09 0.07 0.08 0.07 0.09 0.07 0.08 0.06
25–64 years . . . . . . . . . . . . . . . . 0.63 0.60 0.57 0.52 0.50 0.48 0.45 0.45 0.42 0.45 0.43 0.43 0.45 0.42 0.41 0.38
65 years and over . . . . . . . . . . . . 9.88 10.13 9.67 9.02 9.10 8.82 8.84 9.02 8.26 8.53 8.36 7.82 7.90 7.77 7.80 7.31
Emphysema (492)
0–24 years . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.00 0.00 0.01 0.01 0.01
25–64 years . . . . . . . . . . . . . . . . 2.60 2.50 2.37 2.18 2.19 2.10 2.19 2.23 2.18 2.18 2.19 2.14 2.12 1.99 2.15 2.01
65 years and over . . . . . . . . . . . . 39.37 39.89 37.89 35.55 36.28 35.68 37.67 37.68 36.79 39.39 38.37 38.66 39.67 39.23 41.32 39.86
Asthma (493)
0–24 years . . . . . . . . . . . . . . . . 0.17 0.21 0.21 0.28 0.27 0.26 0.31 0.31 0.34 0.31 0.31 0.33 0.36 0.34 0.38 0.40
25–64 years . . . . . . . . . . . . . . . . 0.94 0.98 1.08 1.10 1.27 1.20 1.29 1.24 1.41 1.47 1.47 1.46 1.52 1.40 1.45 1.59
65 years and over . . . . . . . . . . . . 5.21 5.82 5.79 5.69 6.14 6.37 6.66 6.90 7.32 7.61 8.23 7.80 8.02 7.84 7.90 8.03
Other chronic obstructive pulmonary
diseases and allied conditions
(494–496)
0–24 years . . . . . . . . . . . . . . . . 0.02 0.04 0.05 0.05 0.05 0.04 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.02 0.02 0.02
25–64 years . . . . . . . . . . . . . . . . 5.12 5.73 5.93 5.80 6.30 6.55 6.80 6.72 6.63 6.82 6.95 6.66 6.78 6.61 6.97 6.82
65 years and over . . . . . . . . . . . . 88.28 103.16 110.24 113.67 126.21 131.20 140.19 141.86 142.67 148.14 147.43 152.16 155.55 156.20 171.79 170.12











Table 3. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age categories: United States
1979–94—Con.
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Ulcer of stomach and duodenum
(531–533)
0–24 years . . . . . . . . . . . . . . . . . . 0.05 0.06 0.05 0.04 0.03 0.03 0.03 0.03 0.03 0.04 0.03 0.03 0.02 0.02 0.03 0.03
25–64 years . . . . . . . . . . . . . . . . . 1.28 1.23 1.22 1.15 1.03 1.04 1.01 0.96 0.90 0.89 0.86 0.81 0.83 0.75 0.78 0.77
65 years and over . . . . . . . . . . . . . 14.66 15.22 15.79 16.22 15.17 15.16 15.09 14.29 13.87 13.73 13.50 12.79 12.06 11.98 11.21 11.30
Appendicitis (540–543)
0–24 years . . . . . . . . . . . . . . . . . . 0.07 0.08 0.05 0.06 0.05 0.04 0.04 0.05 0.03 0.04 0.04 0.04 0.03 0.03 0.04 0.03
25–64 years . . . . . . . . . . . . . . . . . 0.17 0.19 0.15 0.13 0.11 0.10 0.10 0.11 0.10 0.10 0.10 0.10 0.09 0.08 0.09 0.08
65 years and over . . . . . . . . . . . . . 1.46 1.35 1.27 1.01 1.10 1.00 1.01 0.98 0.93 0.85 0.83 0.74 0.63 0.72 0.58 0.59
Hernia of abdominal cavity and
intestinal obstruction without mention
of hernia (550–553,560)
0–24 years . . . . . . . . . . . . . . . . . . 0.27 0.24 0.22 0.21 0.18 0.18 0.15 0.19 0.17 0.14 0.15 0.16 0.14 0.14 0.13 0.12
25–64 years . . . . . . . . . . . . . . . . . 0.74 0.74 0.61 0.59 0.55 0.53 0.52 0.53 0.52 0.52 0.51 0.48 0.51 0.47 0.44 0.50
65 years and over . . . . . . . . . . . . . 13.37 13.14 12.81 11.61 11.71 11.83 11.74 11.59 11.54 11.38 11.00 11.42 11.71 11.32 10.81 10.79
Chronic liver disease and cirrhosis
(571)
0–24 years . . . . . . . . . . . . . . . . . . 0.16 0.18 0.16 0.15 0.12 0.13 0.10 0.11 0.11 0.09 0.09 0.08 0.07 0.07 0.08 0.06
25–64 years . . . . . . . . . . . . . . . . . 18.87 18.92 17.41 15.93 15.38 14.90 14.40 13.66 13.60 13.54 13.13 12.40 11.91 11.48 11.31 11.26
65 years and over . . . . . . . . . . . . . 37.42 38.97 38.68 36.97 36.10 37.06 35.75 35.37 34.19 34.06 35.22 34.21 33.45 33.14 32.22 31.99
Cholelithiasis and other disorders of
gallbladder (574–575)
0–24 years . . . . . . . . . . . . . . . . . . 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.01 0.02
25–64 years . . . . . . . . . . . . . . . . . 0.43 0.44 0.37 0.36 0.37 0.35 0.34 0.28 0.31 0.31 0.30 0.27 0.27 0.29 0.25 0.28
65 years and over . . . . . . . . . . . . . 8.45 8.59 7.93 7.35 7.12 7.20 6.83 6.83 6.79 6.70 6.40 6.41 5.79 5.76 5.36 5.36
Nephritis, nephrotic syndrome, and
nephrosis (580–589)
0–24 years . . . . . . . . . . . . . . . . . . 0.45 0.40 0.44 0.40 0.37 0.43 0.40 0.39 0.34 0.34 0.30 0.25 0.28 0.27 0.27 0.24
25–64 years . . . . . . . . . . . . . . . . . 2.91 2.91 2.76 2.77 2.77 2.79 2.89 2.86 2.81 2.90 2.64 2.56 2.45 2.46 2.53 2.32
65 years and over . . . . . . . . . . . . . 39.40 41.53 42.32 43.31 44.61 46.38 48.12 47.95 47.62 47.00 43.89 42.55 42.78 43.54 45.00 43.88
Acute glomerulonephritis and nephrotic
syndrome (580–581)
0–24 years . . . . . . . . . . . . . . . . 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.02 0.02 0.02 0.02 0.01
25–64 years . . . . . . . . . . . . . . . . 0.06 0.07 0.05 0.06 0.06 0.06 0.06 0.05 0.04 0.05 0.05 0.05 0.05 0.04 0.04 0.04
65 years and over . . . . . . . . . . . . 0.83 0.72 0.74 0.68 0.80 0.68 0.71 0.59 0.58 0.63 0.62 0.54 0.57 0.56 0.50 0.54
Chronic glomerulonephritis, nephritis and
nephropathy, not specified as acute or
chronic, and renal sclerosis, unspecified
(582–583,587)
0–24 years . . . . . . . . . . . . . . . . 0.05 0.04 0.04 0.04 0.04 0.03 0.02 0.03 0.03 0.02 0.03 0.02 0.03 0.01 0.02 0.01
25–64 years . . . . . . . . . . . . . . . . 0.48 0.43 0.38 0.36 0.31 0.32 0.24 0.24 0.23 0.24 0.24 0.25 0.21 0.20 0.20 0.19
65 years and over . . . . . . . . . . . . 5.91 5.54 4.95 4.53 4.35 4.02 3.51 3.29 3.12 3.10 3.01 2.97 2.93 2.84 3.01 2.88
Renal failure, disorders resulting from
impaired renal function, and small kidney
of unknown cause (584–586,588–589)
0–24 years . . . . . . . . . . . . . . . . 0.37 0.34 0.37 0.35 0.31 0.38 0.37 0.35 0.30 0.31 0.25 0.20 0.23 0.24 0.23 0.21
25–64 years . . . . . . . . . . . . . . . . 2.37 2.41 2.33 2.36 2.40 2.41 2.59 2.57 2.54 2.61 2.35 2.26 2.19 2.22 2.29 2.10
65 years and over . . . . . . . . . . . . 32.66 35.27 36.63 38.10 39.46 41.68 43.90 44.07 43.92 43.28 40.26 39.05 39.27 40.13 41.49 40.47











Table 3. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age categories: United States
1979–94—Con.
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Infections of kidney (590)
0–24 years . . . . . . . . . . . . . . . . . . 0.03 0.02 0.02 0.02 0.02 0.02 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.01 0.01 0.01
25–64 years . . . . . . . . . . . . . . . . . 0.33 0.31 0.27 0.24 0.22 0.23 0.18 0.19 0.17 0.17 0.14 0.14 0.13 0.12 0.12 0.10
65 years and over . . . . . . . . . . . . . 7.61 7.12 5.76 5.43 4.87 4.71 4.46 3.97 3.72 3.26 2.82 2.50 2.24 1.93 1.77 1.70
Hyperplasia of prostate (600)
0–24 years . . . . . . . . . . . . . . . . . . – – – – – – – – – – – – – – – –
25–64 years . . . . . . . . . . . . . . . . . 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.01
65 years and over . . . . . . . . . . . . . 2.38 2.12 1.89 1.67 1.45 1.29 1.14 1.16 1.05 1.00 0.96 0.95 0.88 0.78 0.78 0.79
Complications of pregnancy,
childbirth, and the puerperium
(630–676)
0–24 years . . . . . . . . . . . . . . . . . . 0.12 0.11 0.12 0.09 0.12 0.08 0.10 0.10 0.08 0.12 0.11 0.12 0.12 0.13 0.10 0.13
25–64 years . . . . . . . . . . . . . . . . . 0.20 0.21 0.17 0.18 0.15 0.17 0.16 0.14 0.14 0.17 0.17 0.18 0.17 0.15 0.16 0.16
65 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Pregnancy with abortive outcome
(630–638)
0–24 years . . . . . . . . . . . . . . . . 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.03 0.02 0.02 0.02 0.02 0.02 0.02
25–64 years . . . . . . . . . . . . . . . . 0.03 0.04 0.03 0.03 0.03 0.03 0.02 0.02 0.02 0.03 0.02 0.03 0.02 0.03 0.02 0.02
65 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other complications of pregnancy,
childbirth, and the puerperium (640–676)
0–24 years . . . . . . . . . . . . . . . . 0.10 0.09 0.10 0.07 0.10 0.06 0.08 0.08 0.07 0.10 0.09 0.10 0.09 0.11 0.08 0.12
25–64 years . . . . . . . . . . . . . . . . 0.17 0.17 0.14 0.14 0.12 0.14 0.14 0.12 0.11 0.14 0.14 0.15 0.14 0.13 0.14 0.14
65 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Congenital anomalies (740–759)
0–24 years . . . . . . . . . . . . . . . . . . 11.67 11.69 11.14 11.13 10.60 10.60 10.19 9.91 9.59 9.74 9.50 9.40 8.71 8.45 8.29 7.96
25–64 years . . . . . . . . . . . . . . . . . 1.53 1.55 1.43 1.37 1.37 1.40 1.28 1.28 1.31 1.33 1.37 1.35 1.35 1.38 1.44 1.42
65 years and over . . . . . . . . . . . . . 2.97 3.15 3.08 3.12 3.13 2.99 3.00 3.23 3.06 3.30 3.48 3.70 3.81 4.02 4.31 4.22
Certain conditions originating in the
perinatal period (760–779)
0–24 years . . . . . . . . . . . . . . . . . . 24.27 22.98 21.29 20.26 18.78 18.77 18.58 17.66 17.48 17.22 17.25 15.91 14.87 13.96 13.67 13.28
25–64 years . . . . . . . . . . . . . . . . . 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
65 years and over . . . . . . . . . . . . . 0.01 0.01 0.00 0.01 0.01 – 0.00 0.01 0.01 0.00 0.01 0.01 0.00 0.02 0.02 0.01
Birth trauma, intrauterine hypoxia, birth
asphyxia, and respiratory distress
syndrome (767–769)
0–24 years . . . . . . . . . . . . . . . . 8.30 7.62 6.57 6.02 5.23 5.14 5.04 4.51 4.18 3.99 4.26 3.49 3.03 2.60 2.37 2.18
25–64 years . . . . . . . . . . . . . . . . 0.00 0.00 0.00 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.01
65 years and over . . . . . . . . . . . . – – – 0.00 – – – – – – 0.00 – – 0.00 0.01 0.01
Other conditions originating in the perinatal
period (760–766,770–779)
0–24 years . . . . . . . . . . . . . . . . 15.97 15.36 14.71 14.24 13.56 13.63 13.54 13.15 13.30 13.23 12.99 12.42 11.84 11.36 11.30 11.10
25–64 years . . . . . . . . . . . . . . . . 0.01 0.01 0.00 0.00 0.01 0.01 0.00 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.01
65 years and over . . . . . . . . . . . . 0.01 0.01 0.00 0.00 0.01 – 0.00 0.01 0.01 0.00 0.01 0.01 0.00 0.01 0.01 0.00











Table 3. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age categories: United States
1979–94—Con.
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Symptoms, signs, and ill-defined
conditions (780–799)
0–24 years . . . . . . . . . . . . . . . . . . 7.43 7.50 7.27 7.22 7.02 6.99 6.96 7.23 7.34 7.57 7.42 6.99 6.80 6.31 6.34 5.69
25–64 years . . . . . . . . . . . . . . . . . 6.94 6.99 7.28 7.40 6.62 6.48 6.84 6.99 7.47 6.87 6.15 5.34 5.15 4.68 5.56 5.01
65 years and over . . . . . . . . . . . . . 42.76 44.45 44.27 43.12 43.62 43.66 43.94 42.39 38.77 37.56 28.18 23.76 23.97 23.46 27.15 26.41
All other diseases (Residual)
0–24 years . . . . . . . . . . . . . . . . . . 7.32 7.19 6.82 6.39 6.43 6.29 6.16 6.08 5.61 5.58 5.78 5.50 5.54 5.30 5.37 5.07
25–64 years . . . . . . . . . . . . . . . . . 29.27 29.85 29.11 27.73 28.80 29.01 31.37 33.41 28.75 29.39 28.60 28.06 28.18 27.76 28.28 28.49
65 years and over . . . . . . . . . . . . . 229.01 246.25 247.36 251.33 268.12 280.05 296.94 303.77 315.63 322.11 323.39 321.26 321.20 320.49 338.79 347.74
Accidents and adverse effects
(E800–E949)
0–24 years . . . . . . . . . . . . . . . . . . 37.75 36.87 33.59 31.12 29.48 29.29 29.00 30.15 29.07 29.10 27.22 25.98 25.14 22.67 23.26 23.13
25–64 years . . . . . . . . . . . . . . . . . 41.79 41.47 39.92 36.34 35.16 34.82 34.58 34.59 34.35 34.87 34.41 33.17 31.08 30.30 31.46 31.48
65 years and over . . . . . . . . . . . . . 82.49 83.03 76.94 72.73 73.21 73.25 73.43 72.04 72.33 73.69 71.76 68.66 66.76 65.91 66.60 67.04
Motor vehicle accidents (E810–E825)
0–24 years . . . . . . . . . . . . . . . . 24.17 23.57 21.64 19.54 18.56 19.15 18.97 20.18 19.64 19.91 18.35 17.75 16.72 15.02 15.36 15.66
25–64 years . . . . . . . . . . . . . . . . 22.51 22.44 21.89 18.92 18.27 18.73 18.36 18.60 18.96 19.05 18.83 18.60 16.75 15.78 15.88 15.78
65 years and over . . . . . . . . . . . . 22.85 21.77 21.70 19.71 19.74 20.95 20.63 21.03 21.75 22.50 22.37 21.75 20.71 20.51 20.54 21.35
All other accidents and adverse effects
(E800–807, E826–E949)
0–24 years . . . . . . . . . . . . . . . . 13.58 13.30 11.96 11.58 10.92 10.14 10.03 9.97 9.43 9.19 8.87 8.23 8.42 7.65 7.90 7.46
25–64 years . . . . . . . . . . . . . . . . 19.28 19.02 18.03 17.42 16.89 16.09 16.21 15.98 15.39 15.82 15.58 14.56 14.34 14.51 15.58 15.70
65 years and over . . . . . . . . . . . . 59.64 61.26 55.24 53.01 53.47 52.30 52.80 51.01 50.58 51.19 49.39 46.91 46.05 45.40 46.06 45.69
Suicide (E950–E959)
0–24 years . . . . . . . . . . . . . . . . . . 5.37 5.34 5.33 5.30 5.20 5.49 5.71 5.74 5.62 5.71 5.75 5.83 5.78 5.80 6.00 6.14
25–64 years . . . . . . . . . . . . . . . . . 16.15 15.77 16.16 16.12 15.72 15.91 15.45 16.03 15.71 15.20 15.03 15.26 15.16 14.76 14.89 14.80
65 years and over . . . . . . . . . . . . . 18.55 17.54 16.88 18.19 18.99 19.63 20.01 21.25 21.29 20.54 19.70 19.84 18.84 18.28 18.08 17.15
Homicide and legal intervention
(E960–E978)
0–24 years . . . . . . . . . . . . . . . . . . 7.09 7.63 7.25 6.87 6.11 6.11 6.07 6.98 6.87 7.58 8.24 9.61 10.75 10.67 11.28 10.83
25–64 years . . . . . . . . . . . . . . . . . 13.57 14.32 13.83 12.76 11.36 10.92 10.81 11.33 10.72 10.84 11.06 11.62 11.97 11.25 11.18 10.65
65 years and over . . . . . . . . . . . . . 5.26 5.60 4.95 4.90 4.46 4.25 4.31 4.47 4.52 4.38 4.15 3.94 4.09 3.78 3.68 3.44
All other external causes
(E980–E999)
0–24 years . . . . . . . . . . . . . . . . . . 1.08 0.97 0.92 0.78 0.74 0.72 0.61 0.66 0.66 0.68 0.55 0.49 0.51 0.51 0.65 0.66
25–64 years . . . . . . . . . . . . . . . . . 2.25 2.10 2.03 1.83 1.74 1.65 1.61 1.75 1.63 1.62 1.49 1.30 1.34 1.62 1.89 1.88
65 years and over . . . . . . . . . . . . . 1.68 1.73 1.78 1.32 1.36 1.37 1.12 1.18 1.13 1.15 0.88 0.77 0.77 0.75 0.83 0.76
Human immunodeficiency virus
infection1 (*042–*044)
0–24 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0.78 0.85 0.99 0.93 1.06 1.03 1.15 1.22
25–64 years . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10.15 12.41 16.39 18.61 21.41 24.06 26.40 29.50
65 years and over . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.15 1.37 1.49 1.63 1.97 2.22 2.28 2.45











Table 3. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease by three broad age categories: United States
1979–94—Con.
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Alzheimer’s disease2 (331.0)
0–24 years . . . . . . . . . . . . . . . . . . – – – 0.00 – 0.00 0.00 – – – – 0.00 – – 0.00 0.00
25–64 years . . . . . . . . . . . . . . . . . 0.16 0.22 0.22 0.28 0.30 0.30 0.33 0.33 0.33 0.34 0.29 0.27 0.27 0.23 0.26 0.28
65 years and over . . . . . . . . . . . . . 2.45 3.77 5.03 7.41 12.46 17.01 21.56 23.71 27.11 28.51 29.23 29.64 29.25 28.92 32.19 34.82
0.0 Quantity more than zero but less than 0.05.
. . . Category not applicable.
– Quantity zero.
* Beginning with data year 1987, the National Center for Health Statistics introduced categories *042–*044 for classifying and coding Human immunodeficiency virus infection. The asterisks indicate that these categories are not part of the Ninth Revision,
International Classification of Diseases, 1975.
1Included in All other infectious and parasitic diseases shown above.











Table 4. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease: United States, 1 979–94
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
All causes . . . . . . . . . . . . . . . . . . . . . . . . . . . 577.05 585.77 568.60 554.73 552.48 548.11 548.83 544.78 539.21 539.90 528.01 520.24 513.76 504.46 513.26 507.40
Shigellosis and amebiasis . . . . . . . . . . (004,006) 0.02 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Certain other intestinal infections . . . . . . (007–009) 0.10 0.12 0.12 0.11 0.11 0.11 0.09 0.11 0.09 0.08 0.09 0.11 0.12 0.13 0.15 0.19
Tuberculosis . . . . . . . . . . . . . . . . . . (010–018) 0.67 0.64 0.62 0.55 0.55 0.53 0.53 0.53 0.52 0.55 0.56 0.52 0.48 0.46 0.43 0.38
Tuberculosis of respiratory system . . . (010–012) 0.55 0.53 0.51 0.44 0.43 0.41 0.40 0.41 0.40 0.42 0.42 0.38 0.36 0.35 0.33 0.27
Other tuberculosis . . . . . . . . . . . . . (013–018) 0.12 0.12 0.12 0.11 0.11 0.13 0.12 0.12 0.11 0.13 0.13 0.14 0.12 0.11 0.10 0.10
Whooping cough . . . . . . . . . . . . . . . . . . (033) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 – 0.00 0.00 0.00
Streptococcal sore throat, scarlatina,
and erysipelas . . . . . . . . . . . . . . . . (034–035) 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00
Meningococcal infection . . . . . . . . . . . . . . (036) 0.18 0.17 0.20 0.15 0.13 0.13 0.11 0.12 0.11 0.11 0.11 0.09 0.08 0.08 0.10 0.11
Septicemia . . . . . . . . . . . . . . . . . . . . . . (038) 2.33 2.64 2.85 3.01 3.39 3.73 4.11 4.36 4.52 4.60 4.17 4.10 4.08 4.01 4.07 4.00
Acute poliomyelitis . . . . . . . . . . . . . . . . . (045) 0.00 0.00 – – – – 0.00 – – 0.00 – – 0.00 – – –
Measles . . . . . . . . . . . . . . . . . . . . . . . . (055) 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.03 0.01 0.00 – –
Viral hepatitis . . . . . . . . . . . . . . . . . . . . . (070) 0.29 0.31 0.33 0.30 0.32 0.31 0.33 0.34 0.40 0.42 0.49 0.50 0.58 0.62 0.77 0.92
Syphilis . . . . . . . . . . . . . . . . . . . . . (090–097) 0.05 0.04 0.04 0.04 0.03 0.03 0.02 0.02 0.03 0.02 0.03 0.03 0.03 0.03 0.02 0.02
All other infectious and parasitic diseases . . . (001–
003,005, 020–032,037,039–041,*042–*044,046–
054,056–066, 071–088,098–139) 1.32 1.42 1.46 1.53 1.69 2.10 2.59 3.27 7.41 8.72 10.91 11.97 13.34 14.65 15.91 17.51
Malignant neoplasms, including neoplasms of
lymphatic and hematopoietic tissues . . . (140–208) 130.79 132.77 131.71 132.77 133.06 134.06 134.35 134.16 133.97 133.96 134.49 135.01 134.48 133.06 132.62 131.50
Malignant neoplasms of lip, oral cavity,
and pharynx . . . . . . . . . . . . . . . . (140–149) 2.97 2.91 2.84 2.79 2.75 2.71 2.61 2.56 2.44 2.48 2.42 2.44 2.38 2.28 2.29 2.15
Malignant neoplasms of digestive organs
and peritoneum . . . . . . . . . . . . . . (150–159) 33.13 32.98 32.47 32.22 31.97 32.20 31.71 31.15 30.88 30.32 30.30 30.25 29.89 29.57 29.47 29.27
Malignant neoplasms of respiratory and
intrathoracic organs . . . . . . . . . . . (160–165) 35.22 36.39 36.65 37.58 38.03 38.59 39.09 39.31 40.04 40.33 40.78 41.38 41.13 40.83 40.76 40.13
Malignant neoplasm of breast . . . . . . . (174–175 12.23 12.47 12.49 12.53 12.48 12.76 12.80 12.70 12.63 12.76 12.69 12.67 12.44 11.99 11.79 11.63
Malignant neoplasms of genital organs (179–187) 13.60 13.62 13.37 13.27 13.31 13.09 13.08 13.21 13.03 13.15 13.26 13.64 13.56 13.50 13.19 13.16
Malignant neoplasms of urinary organs (188–189) 5.21 5.22 5.14 5.20 5.10 5.03 5.05 5.02 5.01 4.95 5.06 5.08 5.12 5.10 5.06 5.10
Malignant neoplasms of all other and
unspecified sites . . . . . . . .(170–173,190–199) 16.42 16.86 16.83 16.99 17.21 17.39 17.62 17.75 17.73 17.65 17.33 16.87 17.06 16.92 17.21 17.03
Leukemia . . . . . . . . . . . . . . . . . . . (204–208) 5.26 5.37 5.15 5.16 5.11 5.12 5.06 4.99 4.89 4.86 4.98 4.98 4.95 4.95 4.92 4.85
Other malignant neoplasms of lymphatic
and hematopoietic tissues . . . . . . . . (200–203) 6.75 6.93 6.79 7.03 7.09 7.17 7.32 7.46 7.32 7.45 7.67 7.71 7.95 7.91 7.94 8.19
Benign neoplasms, carcinoma in situ, and
neoplasms of uncertain behavior and of unspecified
nature . . . . . . . . . . . . . . . . . . . . . (210–239) 1.91 1.97 1.91 1.93 1.87 1.80 1.85 1.83 1.72 1.75 1.69 1.69 1.69 1.68 1.72 1.72
Diabetes mellitus . . . . . . . . . . . . . . . . . . (250) 9.77 10.12 9.81 9.59 9.89 9.51 9.68 9.65 9.85 10.21 11.61 11.65 11.78 11.84 12.45 12.92
Nutritional deficiencies . . . . . . . . . . . . (260–269) 0.52 0.53 0.50 0.50 0.52 0.49 0.53 0.51 0.50 0.50 0.50 0.48 0.46 0.48 0.50 0.49
Anemias . . . . . . . . . . . . . . . . . . . . . (280–285) 0.93 0.92 0.90 0.87 0.91 0.88 0.90 0.87 0.89 0.86 0.91 0.91 0.88 0.92 0.88 0.90
Meningitis . . . . . . . . . . . . . . . . . . . . (320–322) 0.57 0.58 0.55 0.49 0.48 0.44 0.43 0.41 0.41 0.40 0.37 0.35 0.28 0.26 0.25 0.25
Major cardiovascular diseases . . . . . . . (390–448) 254.20 255.99 245.88 238.80 235.94 229.26 225.01 218.01 212.03 208.28 196.18 189.83 184.98 180.36 181.75 176.77
Diseases of heart . . . . . . (390–398,402,404–429) 199.56 202.01 195.25 190.90 189.58 184.26 181.36 175.97 170.79 167.67 157.52 152.03 148.24 144.33 145.27 140.38
Rheumatic fever and rheumatic heart
disease . . . . . . . . . . . . . . . . . . . (390–398) 2.61 2.57 2.34 2.17 2.09 2.02 1.89 1.79 1.72 1.68 1.54 1.50 1.43 1.35 1.32 1.24
Hypertensive heart disease . . . . . . . . . . . (402) 6.04 5.90 5.74 5.58 5.54 5.35 5.29 5.09 5.07 4.98 4.90 4.83 4.77 4.81 4.89 4.98
Hypertensive heart and renal disease . . . . (404) 0.88 0.87 0.77 0.67 0.66 0.61 0.60 0.52 0.53 0.50 0.48 0.49 0.48 0.47 0.46 0.46
Ischemic heart disease . . . . . . . . . . (410–414) 149.77 149.86 143.57 139.62 135.80 130.21 126.09 119.47 114.70 111.13 106.21 102.54 99.12 95.71 94.92 91.45
Acute myocardial infarction . . . . . . . . . . . (410) 88.23 85.96 81.99 79.63 76.34 72.71 69.61 64.68 61.30 58.26 56.45 53.73 51.50 49.09 47.52 45.65











Table 4. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease: United States, 1 979–94—Con.
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Other acute and subacute forms of
ischemic heart disease . . . . . . . . . . . . .(411) 1.46 1.44 1.35 1.22 1.16 1.12 1.10 1.04 0.92 0.85 0.83 0.84 0.80 0.75 0.68 0.63
Angina pectoris . . . . . . . . . . . . . . . . . . (413) 0.14 0.15 0.15 0.16 0.18 0.21 0.21 0.23 0.22 0.21 0.22 0.20 0.20 0.18 0.17 0.16
Old myocardial infarction and other forms
of chronic ischemic heart disease . . . (412,414) 59.93 62.30 60.09 58.61 58.12 56.18 55.16 53.53 52.26 51.80 48.72 47.77 46.63 45.70 46.55 45.01
Other diseases of endocardium . . . . . . . . (424) 1.85 1.97 1.96 1.99 2.05 2.07 2.19 2.24 2.35 2.43 2.44 2.54 2.52 2.57 2.60 2.59
All other forms of heart
disease . . . . . . . . . . . . . .(415–423,425–429) 38.41 40.83 40.88 40.88 43.44 44.00 45.31 46.85 46.44 46.95 41.95 40.13 39.92 39.42 41.08 39.66
Hypertension with or without renal
disease . . . . . . . . . . . . . . . . . . . (401,403) 1.91 2.02 1.91 1.84 1.84 1.84 1.80 1.81 1.81 1.85 1.87 1.91 1.94 2.03 2.17 2.21
Cerebrovascular diseases . . . . . . . . (430–438) 41.58 40.76 38.18 35.91 34.52 33.55 32.45 31.13 30.45 29.96 28.32 27.69 26.78 26.20 26.51 26.54
Intracerebral and other intracranial
hemorrhage . . . . . . . . . . . . . . . . (431–432) 6.61 6.22 5.98 5.78 5.53 5.66 5.63 5.49 5.47 5.51 5.24 5.17 5.06 5.06 5.05 5.05
Cerebral thrombosis and unspecified
occlusion of cerebral arteries . . . . (434.0,434.9) 8.13 7.58 6.71 5.97 5.47 5.12 4.86 4.56 4.26 3.96 3.57 3.29 2.94 2.65 2.53 2.40
Cerebral embolism . . . . . . . . . . . . . . . (434.1) 0.23 0.21 0.21 0.18 0.18 0.18 0.17 0.17 0.16 0.15 0.14 0.13 0.12 0.12 0.12 0.13
All other and late effects of cerebrovascular
diseases . . . . . . . . . . . . . (430,433,435–438) 26.62 26.74 25.29 23.97 23.35 22.59 21.79 20.91 20.56 20.34 19.37 19.11 18.65 18.36 18.81 18.97
Atherosclerosis . . . . . . . . . . . . . . . . . . (440) 5.66 5.68 5.18 4.85 4.65 4.17 4.00 3.72 3.64 3.47 2.98 2.75 2.58 2.43 2.41 2.34
Other diseases of arteries, arterioles,
and capillaries . . . . . . . . . . . . . . . (441–448) 5.49 5.52 5.36 5.29 5.34 5.44 5.40 5.38 5.35 5.33 5.49 5.45 5.43 5.37 5.40 5.29
Acute bronchitis and bronchiolitis . . . . . . . . (466) 0.18 0.19 0.17 0.14 0.15 0.14 0.15 0.14 0.14 0.15 0.15 0.14 0.14 0.14 0.14 0.13
Pneumonia and influenza . . . . . . . . . . (480–487) 11.16 12.91 12.25 10.90 11.85 12.22 13.47 13.63 13.19 14.33 13.82 14.03 13.36 12.67 13.48 13.02
Pneumonia . . . . . . . . . . . . . . . . . . (480–486) 11.02 12.36 11.64 10.75 11.58 12.01 13.11 13.31 13.08 14.01 13.54 13.69 13.16 12.50 13.31 12.83
Influenza . . . . . . . . . . . . . . . . . . . . . . (487) 0.14 0.55 0.61 0.15 0.27 0.21 0.36 0.33 0.12 0.32 0.28 0.34 0.20 0.16 0.17 0.19
Chronic obstructive pulmonary diseases
and allied conditions . . . . . . . . . . . . (490–496) 14.56 15.94 16.33 16.21 17.48 17.79 18.78 18.88 18.87 19.58 19.56 19.67 20.10 19.84 21.37 21.04
Bronchitis, chronic and unspecified . . . (490–491) 1.05 1.03 0.99 0.92 0.91 0.88 0.86 0.87 0.81 0.84 0.82 0.78 0.80 0.77 0.77 0.72
Emphysema . . . . . . . . . . . . . . . . . . . . (492) 4.00 3.99 3.78 3.53 3.59 3.50 3.68 3.70 3.61 3.79 3.73 3.72 3.78 3.69 3.91 3.74
Asthma . . . . . . . . . . . . . . . . . . . . . . . (493) 0.90 0.98 1.03 1.06 1.18 1.15 1.23 1.23 1.35 1.39 1.43 1.41 1.46 1.38 1.43 1.52
Other chronic obstructive pulmonary diseases
and allied conditions . . . . . . . . . . . (494–496) 8.61 9.94 10.53 10.71 11.81 12.27 13.01 13.09 13.10 13.56 13.58 13.76 14.05 14.01 15.26 15.07
Ulcer of stomach and duodenum . . . . . . (531–533) 1.67 1.68 1.71 1.70 1.57 1.57 1.55 1.47 1.41 1.41 1.37 1.29 1.25 1.21 1.17 1.17
Appendicitis . . . . . . . . . . . . . . . . . . (540–543) 0.22 0.22 0.18 0.16 0.15 0.14 0.14 0.15 0.13 0.13 0.12 0.12 0.11 0.11 0.10 0.10
Hernia of abdominal cavity and intestinal obstruction
without mention of hernia . . . . . . .(550–553,560) 1.41 1.37 1.28 1.18 1.16 1.15 1.13 1.14 1.13 1.10 1.07 1.09 1.12 1.07 1.02 1.04
Chronic liver disease and cirrhosis . . . . . . . (571) 12.06 12.19 11.41 10.55 10.21 10.03 9.68 9.29 9.18 9.13 9.01 8.57 8.27 8.03 7.89 7.84
Cholelithiasis and other disorders of
gallbladder . . . . . . . . . . . . . . . . . . (574–575) 0.80 0.81 0.73 0.69 0.68 0.67 0.64 0.61 0.62 0.62 0.59 0.58 0.54 0.54 0.50 0.52
Nephritis, nephrotic syndrome, and
nephrosis . . . . . . . . . . . . . . . . . . . (580–589) 4.35 4.47 4.46 4.53 4.60 4.75 4.91 4.88 4.81 4.81 4.46 4.30 4.27 4.33 4.47 4.27
Acute glomerulonephritis and nephrotic
syndrome . . . . . . . . . . . . . . . . . . (580–581) 0.10 0.09 0.08 0.08 0.09 0.08 0.09 0.07 0.07 0.07 0.08 0.07 0.07 0.07 0.06 0.06
Chronic glomerulonephritis, nephritis and
nephropathy, not specified as acute or chronic,
and renal sclerosis, unspecified . .(582–583,587) 0.67 0.61 0.55 0.50 0.47 0.45 0.37 0.36 0.34 0.34 0.34 0.34 0.32 0.30 0.32 0.30











Table 4. Age-adjusted death rates for 72 selected causes of death, Human immunodeficiency virus infection, and Alzheimer’s disease: United States, 1 979–94—Con.
[Age-adjusted death rates per 100,000 U.S. standard population]
Cause of death (ICD–9 category) 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994
Renal failure, disorders resulting from impaired
renal function, and small kidney of
unknown cause . . . . . . . . .(584–586,588–589) 3.58 3.77 3.83 3.94 4.04 4.22 4.46 4.45 4.40 4.40 4.04 3.89 3.89 3.96 4.09 3.91
Infections of kidney . . . . . . . . . . . . . . . . . (590) 0.70 0.65 0.53 0.50 0.45 0.44 0.40 0.37 0.35 0.31 0.27 0.25 0.23 0.19 0.18 0.17
Hyperplasia of prostate . . . . . . . . . . . . . . (600) 0.17 0.16 0.14 0.12 0.11 0.10 0.08 0.09 0.08 0.08 0.07 0.07 0.07 0.06 0.06 0.06
Complications of pregnancy, childbirth,
and the puerperium . . . . . . . . . . . . . (630–676) 0.16 0.15 0.14 0.13 0.12 0.12 0.12 0.11 0.10 0.14 0.13 0.14 0.13 0.13 0.12 0.14
Pregnancy with abortive outcome . . . . (630–638) 0.03 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.02 0.02 0.02
Other complications of pregnancy, childbirth,
and the puerperium . . . . . . . . . . . . (640–676) 0.13 0.12 0.12 0.10 0.10 0.10 0.10 0.09 0.09 0.11 0.11 0.12 0.11 0.11 0.10 0.12
Congenital anomalies . . . . . . . . . . . . . (740–759) 6.01 6.04 5.74 5.71 5.48 5.49 5.25 5.14 5.01 5.10 5.03 4.99 4.70 4.62 4.60 4.44
Certain conditions originating in the perinatal
period . . . . . . . . . . . . . . . . . . . . . (760–779) 10.49 9.93 9.20 8.76 8.12 8.12 8.03 7.63 7.56 7.44 7.46 6.88 6.43 6.04 5.91 5.75
Birth trauma, intrauterine hypoxia, birth asphyxia,
and respiratory distress syndrome . . . (767–769) 3.59 3.29 2.84 2.60 2.26 2.22 2.18 1.95 1.81 1.73 1.84 1.51 1.31 1.12 1.03 0.94
Other conditions originating in the perinatal
period . . . . . . . . . . . . . . .(760–766,770–779) 6.90 6.64 6.36 6.15 5.86 5.89 5.85 5.69 5.75 5.72 5.62 5.37 5.12 4.91 4.89 4.80
Symptoms, signs, and ill–defined
conditions . . . . . . . . . . . . . . . . . . . (780–799) 9.61 9.78 9.81 9.77 9.33 9.25 9.43 9.52 9.56 9.27 8.21 7.31 7.15 6.67 7.37 6.77
All other diseases . . . . . . . . . . . . . . . (Residual) 33.47 34.88 34.43 33.83 35.53 36.39 38.67 40.12 38.40 39.15 38.93 38.39 38.47 38.11 39.65 40.24
Accidents and adverse effects . . . . . (E800–E949) 42.83 42.33 39.72 36.58 35.31 35.07 34.83 35.23 34.67 35.03 33.86 32.49 30.96 29.44 30.32 30.30
Motor vehicle accidents . . . . . . . . (E810–E825) 23.25 22.88 21.77 19.24 18.49 19.06 18.78 19.45 19.45 19.66 18.86 18.45 17.01 15.78 15.97 16.11
All other accidents and adverse
effects . . . . . . . . . . . (E800–E807,E826–E949) 19.58 19.45 17.95 17.34 16.82 16.00 16.05 15.78 15.22 15.38 15.00 14.04 13.95 13.66 14.35 14.19
Suicide . . . . . . . . . . . . . . . . . . . (E950–E959) 11.65 11.39 11.53 11.59 11.40 11.66 11.55 11.94 11.73 11.47 11.34 11.50 11.36 11.13 11.27 11.21
Homicide and legal intervention . . . . (E960–E978) 10.20 10.83 10.38 9.68 8.62 8.38 8.32 8.98 8.63 8.99 9.37 10.23 10.90 10.49 10.71 10.23
All other external causes . . . . . . . . . (E980-E999) 1.71 1.59 1.53 1.34 1.28 1.23 1.14 1.24 1.18 1.18 1.04 0.92 0.95 1.08 1.28 1.27
Human immunodeficiency virus
infection1 . . . . . . . . . . . . . . . . . . (*042–*044) . . . . . . . . . . . . . . . . . . . . . . . . 5.49 6.66 8.71 9.81 11.28 12.61 13.84 15.42
Alzheimer’s disease2 . . . . . . . . . . . . . . . (331.0) 0.25 0.37 0.45 0.65 1.00 1.32 1.64 1.79 2.02 2.12 2.15 2.17 2.14 2.10 2.33 2.53
0.0 Quantity more than zero but less than 0.05.
. . . Category not applicable.
– Quantity zero.
* Beginning with data year 1987, the National Center for Health Statistics introduced categories *042–*044 for classifying and coding Human immunodeficiency virus infection. These asterisks indicate that these categories are not part of the Ninth Revision,
International Classification of Diseases, 1975.
1Included in All other infectious and parasitic diseases shown above.













Second Workshop Age Adjustment
National Center for Health Statistics





9:00–9:05 a.m. Logistics and introduction—Dr. Rosenberg
9:05–9:15 Welcome and introductions—Dr. Madans
9:15–10:30 10-minute presentations and discussions
10:30–11:00 Break
11:00–12:30 p.m. 10-minute presentations and discussions
12:30–1:30 Lunch
1:30–3:00 Remaining presentations and discussions
3:00–3:30 Break
3:30–4:30 Facilitated discussion to identify salient issues
Friday, June 6
9:00–9:05 a.m. Logistics and messages—Dr. Rosenberg
9:05–10:30 Facilitated discussion to make recommendations
10:30–11:00 Break
11:00–12:00 Facilitated discussion to make recommendations
12:00–12:30 p.m. Closing remarks—Dr. Sondik
12:30 Adjourn
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Comments on Age
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Over 30 years ago, Kitagawa
discussed summary measures and
identified two distinct classes of
demographic indexes (1). The first are
called aggregative indexes, and
age-adjusted (or age-standardized) dea
rates are one example. The general for
is
IA = ∑Ps(x) m(x) /∑Ps(x) (1)
whereIA is an aggregative index,Ps(x)
is the number of persons in a designate
standard population at agex, m(x) is the
rate at agex, and the summations range
over all ages. These indexes aggregate
the number of deaths in terms of a
standard population, and present the
crude death rate of that standard
population. The choice of standard
population is important because differen
standards can yield substantially
different results (2–4).
The second class are called averag
of relatives indexes. They can be writte
IR = (1/n) ∑ [m(x) / ms(x)] (2)
whereIR is an average of relatives
index,ms(x) is a standard rate at agex,
n is the number of age categories, and
the summation ranges from 1 ton. Here
individual rates are compared, and an
average of those ratios is taken. There
no need for a standard population. In
fertility analysis the Total Fertility Rate
(an average of relatives index) is the
preferred measure. In mortality analysis
however, aggregative indexes dominate
Some years ago, I tried to introduce the
del index—the geometric mean of the
age-specific death rates—as an
alternative, but without much success
(5,6). Yet, I remain convinced that it
does matter whether one thinks of
weighted deaths (as in crude orstandardized death rates) or in terms o
patterns of death rates.
I regard the age-specific death rate
as the basic measures. They represent
the behavior of interest, and the age
curve of death rates is remarkably
constant over widely varying levels of
mortality. Figure 1shows that, apart
from level, the age pattern of mortality
changes little as life expectancy at birth
goes from 25 years to 70 years in the
Coale-Demeny Model ‘‘West’’ life tables
(7). That regularity contrasts sharply
with the change in life table death rates
When mortality is very high, most
deaths occur to infants and children. At
contemporary mortality levels, the grea
bulk of deaths occur at the high ages.
Large proportional changes in death
rates at ages under 65 can have only
small effects on standardized death rat
regardless of what standard is used.
Consider the pattern of mortality
differentials by sex for whites in the
United States, 1950, 1960, and 1970,
which is shown infigure 2(8, p.35).
Looking at the sex differential by age,
we see that it varies from around
10 percent at the high ages to over
200 percent at ages 20–24. The averag
differential seems to be around 75 to
80 percent. Yet the ratio of male and
female life expectancies was 9 percent
in 1950, 10 percent in 1960, and
11 percent in 1970. The high death rate
and smaller differentials at the older
ages make the sex differential in
aggregative indexes look much smaller
than it is.
Those considerations lead me to
two recommendations. First, if we
believe aggregative indexes are
appropriate, let the rates determine the
standard. One could choose a life table
with mortality rates similar to the
population to be examined, and use the
age composition of the life table’s
‘‘stationary population’’ as the standard.
For example, we could use the ‘‘West’’
female life table with a life expectancy
at birth of 77.5 years (7). Such a
standard would not be tied to any time
or place, would be conceptually differen
from any crude rate, and could be used
as long as that level of mortality
remains a reasonable approximation.
However, there are a number of
reasons not to emphasize aggregatives,
indexes. As noted, they can seriously
distort the nature of differences between
populations. Furthermore, when
standardized rates differ substantially
from crude rates, those differences can
lead to misunderstandings. To minimize
the difference between crude and
standardized rates, a contemporaneous
population can be taken as the standar
Thus, the age distribution for the year
2000 is a logical choice. The aging of
the U.S. population over the past 60
years makes the 1940 age distribution
quite obsolete.
Implicit in the recommendation for
a year 2000 standard is the idea that th
standard will be changed when crude
and standardized rates begin to differ
appreciably, something that is likely to
occur in 10 to 20 years. Deemphasizing
the standard population makes sense. I
reinforces the principle that careful
analysis must look at the rates
themselves, and not be content with an
single summary measure.
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Figure 1. Age-specific death rates per thousand population. Coale-Demeny (1966) ‘‘West’’ life tables for females.
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Figure 2. Percent differences in mortality rates by sex for whites: United States, 1950, 1960, and 1970.
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